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ABSTRACT 
 
THE CONFORMATIONAL GYMNASTICS OF THE E. COLI SECA MOLECULAR 
MACHINE AND ITS INTERACTIONS WITH SIGNAL SEQUENCES 
MAY 2009 
JENNY LYNN MAKI  
B.S., UNIVERSITY OF MINNESOTA DULUTH 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Lila M. Gierasch 
 
Protein secretion is a selective and regulated process that is essential in all 
organisms. In bacteria the preprotein translocase SecA, either free in the cytosol or 
associated with the SecYEG translocon, recognizes and binds most post-translational 
secretory proteins containing an N-terminal signal sequence. In Gram-negative bacteria, 
the molecular chaperone SecB binds many of the preproteins to keep them in a 
translocation-competent state. Subsequently, SecB delivers the preproteins to the 
translocon-associated SecA, which binds the signal sequence and also interacts with 
mature regions of the preprotein. After the preprotein/SecA/SecYEG complex has 
formed, the energy derived from ATP hydrolysis by SecA coupled with the proton 
motive force drives the insertion of the preprotein through the translocon pore. During the 
translocation reaction, the conformation of SecA dramatically changes from an inactive 
closed form (c-SecA) to one more active and open states. The various crystal structures 
of SecA have provided many structural details about c-SecA. The recent low resolution 
 ix 
crystal structure of a fragment of SecA bound to SecYEG (Zimmer et al., 2008) has 
provided a starting point for structural analysis of the active and open conformation of 
SecA. Previous work in our laboratory demonstrated that an N-terminal proteolytic 
fragment of SecA, SecA64, is an activated form of SecA that with higher affinity signal 
peptides better than c-SecA (Triplett et al., 2001). To correlate the SecA64 results with 
full-length SecA, we determined that SecA in the presence of low concentrations of urea 
has an enhanced ATPase activity similar to translocation level, which is comparable to 
what was observed with SecA64. Analysis by CD and Trp fluorescence indicates the 
presence of an intermediate at 2.2 M urea at 22ºC (termed u-SecA). Using limited 
proteolysis, we determined that u-SecA is in an protease-sensitive conformation that 
mimics the translocation-active form of SecA. These structural rearrangements occur 
primarily in the C-terminal one-third of the protein. Next, we sought to understand the 
signal sequence interactions with c-SecA and translocation-active u-SecA. Using a 
photoactivatable cross-linking approach along with limited proteolysis, two-dimensional 
gels, and domain mapping with region-specific antibodies, the signal sequence-binding 
site was mapped to the interface of NBF II, PPXD, and HSD. The site is the same in both 
forms of SecA but in our data suggests u-SecA that the binding groove as expanded.  
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CHAPTER 1  
INTRODUCTION 
Portions of this chapter are part of a review paper written in collaboration with Eugenia 
M. Clerico and Lila M. Gierasch. (Clerico E.M., Maki, J.L., Gierasch, L.M. Use of 
synthetic signal sequences to explore the protein export machinery. Biopolymers (Peptide 
Science). 2008, 90 (3): 307-319.) 
1.1 General overview of protein secretion 
Secretion is a highly selective and regulated process that is essential for the 
survival of any organism. In all kingdoms of life, the genes that code for proteins are 
translated predominantly by cytosolic ribosomes, yet nascent polypeptide chains are 
targeted to a variety of locations throughout the cell. As newly synthesized proteins 
emerge from the ribosome, they are greeted by a host of chaperones and targeting factors 
that effectively partition the proteins that are cytosolic from those that need to be 
translocated across a membrane (Ullers et al., 2007). In general, proteins that are destined 
for secretion or integration into a membrane contain a zip code called a signal sequence, 
which targets the ribosome nascent chain complex (RNC) or the post-translational 
proteins to the secretory apparatus (von Heijne, 1998). These polypeptides bind to 
secretory components through specific interactions and are translocated across the 
membrane, which is typically the plasma membrane in prokaryotic organisms and the 
endoplasmic reticulum (ER) membrane in eukaryotic organisms. In bacteria, secretory 
proteins are either translocated across another membrane such as the outer membrane or 
are folded into their final native state in the periplasm. In eukaryotes secretory proteins 
are correctly folded in the ER and ultimately trafficked to their final destination such as 
the plasma membrane or an organelle (Clerico et al., 2008). 
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1.2 Signal sequences 
The targeting of nascent polypeptides to their final non-cytoplasmic destination is 
a crucial process in both prokaryotic and eukaryotic organisms.  The targeting of these 
proteins is usually mediated by an N-terminal signal sequence, which directs the post-
translational protein or the RNC to the inner membrane in prokaryotes and the 
endoplasmic reticulum in eukaryotes (Figure 1.1) (Schnell and Hebert, 2003). Despite 
their universal functions in all realms of life, signal sequences lack primary sequence 
homology, even in proteins that are closely related.  Although without primary structure 
homology, signal sequences share a common distribution of residue types and are 
typically 15 to 30 residues in length (Figure 1.2, A). The N-terminus portion of the signal 
sequence, the so-called n-region, has an overall positive charge and is variable in length 
(Gierasch, 1989). It has been suggested that the requirement for the positive charge at the 
N-terminus can be compensated by the addition of a longer hydrophobic core (Hikita and 
Mizushima, 1992). The middle part of a signal sequence called the h-region, is enriched 
several Leu, Ala, Met, Val, Ile, or Phe residues and therefore, is highly hydrophobic. This 
hydrophobic region is the hallmark of a signal sequence and consists of 7 to 13 residues. 
The hydrophobic segment is shorter than a membrane spanning helix but is longer than a 
typical hydrophobic segment found in globular proteins (von Heijne, 1985). The third 
region of the signal sequence, the c-region, is uncharged, polar, and contains the signal 
peptidase cleavage site, A-X-A where X is any amino acid (Gierasch, 1989). The signal 
sequence is typically cleaved during the translocation of the preprotein (von Heijne, 
1990). These general features of signal sequences have likely been evolutionarily  
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Figure 1.1  The Sec secretion pathways 
 
Secretory and integral membrane proteins are targeted to the endoplasmic reticulum (ER) 
membrane in eukaryotes and the plasma membrane in prokaryotes. SRP-mediated 
translocation: The membrane protein (pink) emerges from the ribosome (gray) and SRP 
(light blue) recognizes and binds the signal sequence (red). The nascent chain complex 
(RNC) and SRP are targeted to SRP receptor (dark blue) at the membrane.  Further 
translation of the protein is arrested or retarded at this step in eukaryotes and the nascent 
chain is maintained in an unfolded conformation needed for translocation. The interaction 
between the SRP and the SRP receptor delivers the RNC to the Sec translocon (green) 
and the nascent protein crosses or is inserted into the membrane. SRP is released from it 
receptor to start another targeting cycle. SecA-mediated targeting: After translation by the 
ribosome, the mature regions of the secretory protein interact with the molecular 
chaperone SecB (orange) to prevent protein folding. Through signal sequence 
recognition, the SecB-preprotein complex associates with SecA (purple), which is either 
in the cytosol or associated with the plasma membrane. This complex binds to the 
SecYEG translocon and induces the release of SecB. SecA undergoes conformational 
gymnastics to facilitate preprotein translocation across the inner membrane. Adapted 
from Clerico et al. (Clerico et al., 2008). 
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optimized for the particular passenger protein and the role of the passenger protein in the 
cell (Gierasch, 1989). 
Genetic studies in E. coli have demonstrated that defects in signal sequences can 
be compensated by suppressor mutations in another part of the signal sequence. Early 
genetic work on secretory proteins in E. coli performed by Emr and Silhavy (Emr and 
Silhavy, 1980) demonstrated that most point mutations in the signal sequence did not 
inhibit translocation but some drastic point mutations could block export. Many of the 
mutations that change translocation of a preprotein occur in the hydrophobic core. For 
example, if a residue in the h-region of the λ phage receptor (LamB) signal sequence was 
mutated to a negative residue export was inhibited. Export of LamB can be inhibited by 
the deletion of four residues from the h-region. The fact that the inhibition can be 
reversed by mutation of either Pro9 to Leu or Gly17 to Cys (Figure 1.2, B) (Emr and 
Silhavy, 1980). The importance of both the n- and h-regions has also been assessed using 
the alkaline phosphatase signal sequence. Mutant signal sequences with a negative charge 
at the N-terminus and a highly hydrophobic h-region can be secreted rapidly but a less 
hydrophobic h-region cannot be exported. Therefore, the n- and h-regions are both 
involved in for recognition by the transport machinery (Izard et al., 1996). These results 
demonstrated that the primary structure is not critical for targeting by the signal sequence 
but the positive n-region and even more so the hydrophobic core are very important in the 
correct targeting of preproteins (Gierasch, 1989). 
Even though signal sequences lack primary sequence homology, they are 
interchangeable between proteins even among vastly different organisms. Proteins 
carrying signal sequences from a prokaryotic protein can be secreted in a eukaryotic cell  
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Figure 1.2  General features of signal sequences 
 
A. The three regions of a signal peptide. Adapted from Chou. (Chou, 2003). B. The E. 
coli λ-receptor (LamB) series of signal sequences. The relative position from the start of 
the signal sequence is indicated by the numerals above the amino acid sequence. Deleted 
amino acids are denoted by the dash, inserted amino acids are indicated by bold letters, 
the position of amino acid substitutions are shown by single letters. Adapted from Triplett 
et al. (Triplett et al., 2001). 
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and vice versa (Muller et al., 1982; Talmadge et al., 1980).This ability of signal 
sequences from different organisms to still direct protein secretion implies that the 
recognition mechanisms of secretory machinery have not changed greatly during 
evolution (Briggs and Gierasch, 1986). 
Recent studies in mammalian cells have shown that signal sequences likely have a 
role in the efficiency of preprotein translocation. One example of this is the cell surface 
glycoprotein, prion protein (PrP). Incorrect targeting of this protein to the ER is caused 
by a slight inefficiency of the PrP signal sequence. This inefficiency leads to the 
generation and build-up of both a cytosolic form and an incorrect topologic form of PrP, 
leading to neurodegeneration (Hegde and Bernstein, 2006). If the PrP signal sequence is 
replaced with a more efficient signal sequence such as the one from prolactin, there is an 
increase in the amount of PrP in the correct topological form (Ott and Lingappa, 2004). 
These results suggest that signal sequences not only act as targeting sequences but also 
affect the efficiency of translocation. 
Genetic work in a mutant E. coli strain demonstrated that the removal of four 
hydrophobic residues from the h-region of the LamB signal sequence caused a defect in 
export (Emr and Silhavy, 1983).  In two pseudorevertant strains, LamB was successfully 
exported and genetic examination of these strains demonstrated that each had a secondary 
point mutation within the signal sequence. In one case, the Gly17 was replaced by Cys, 
LamBΔ78r1. In the other case, the Pro9 was replaced by Leu, LamBΔ78r2 (Figure 1.2, 
B). Therefore, the loss of four hydrophobic residues was somehow compensated by 
single residue changes. Since both Gly and Pro can act as helix breakers, it was proposed 
that the signal sequence must adopt α-helical conformation to function. 
  9 
Our group tested the secondary structure hypothesis by using synthetic signal 
peptides in solution as well as in phospholipids monolayers and vesicles (Gierasch et al., 
1985). In solution the LamB signal peptide adopted a largely random conformation as 
monitored by far-ultraviolet (UV) circular dichroism (CD) analysis. In the presence of 
polyfluorinated alcohols, which can mimic the membrane interior, the signal peptide 
become partially helical (Briggs and Gierasch, 1986). This work was extended further to 
examine the deletion and pseudorevertants mutants discovered by Emr and Silhavy (Emr 
and Silhavy, 1983). The deletion mutant remained predominately in a random coil 
conformation in buffer, sodium dodecyl sulfate (SDS) micelles, trifluoroethanol, and 
phospholipid vesicles. The wild type LamB signal peptide as well as the two 
pseudorevertants had random coil conformations in buffer but adopted a much more 
helical structure in the presence of an apolar environment (Briggs and Gierasch, 1986). 
These results are consistent with the hypothesis that signal sequences must adopt an α-
helical structure for function. 
Further studies showed that some non-functional signal sequences adopt α-helical 
structures in apolar environments meaning that the structural conformation itself is not 
sufficient for signal sequence function (McKnight et al., 1989). Therefore, our group used 
surface tensiometry experiments using phospholipids monomers to assess the interactions 
of signal peptides with phospholipids monolayers. The functional LamB signal peptides 
were able to insert into the monolayer but the non-functional signal peptides were only 
able to interact with the phospholipids head groups of the lipids. The non-functional 
signal peptides that can adopt α-helical conformation could only insert into the 
monolayers at high peptide concentrations (Briggs et al., 1985; McKnight et al., 1989). 
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The same biophysical characteristics of the LamB signal peptide are observed in other 
functional and non-functional synthetic signal peptides such as the outer membrane 
protein OmpA (Hoyt and Gierasch, 1991a; Hoyt and Gierasch, 1991b; Rizo et al., 1993). 
At least in the case of the LamB signal sequence, the adjacent mature region of the 
preprotein does not affect the secondary structure or the membrane-binding properties of 
the signal sequence (McKnight et al., 1991). This implies that functional signal sequences 
not only need to be able to adopt an α-helical conformation but also need to be able to 
insert into the phospholipids membrane. 
In spite of their diversity and lack of primary sequence homology, signal 
sequences have very distinct features and properties that specifically direct preproteins to 
the secretory apparatus. Signal sequences are interchangeable between species and are 
tolerant of many mutations. Recently, it has come to light that signal sequences are not 
just simple interchangeable domains that serve as simple targeting motifs but have 
specific properties that have been optimized for the proper biosynthesis of its substrate 
protein (Hegde and Bernstein, 2006).  
1.3. Protein translation and chaperones 
All proteins are synthesized by the decoding of the messenger ribonucleic acids 
(mRNA) by the ribosome. In E. coli the ribosome is made of 55 components and is 
formed by two subunits, 30S and 50S, which together form the 70S particle. This 70S 
ribosome consists of about two-thirds ribosomal RNA (rRNA) and one-third protein. The 
larger 50S subunit is made from two rRNAs, the 23S and the 5S, and 33 proteins. The 
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smaller 30S subunit is composed of the 16S rRNA and 21 ribosomal proteins 
(Kaczanowska and Ryden-Aulin, 2007). 
The translation process can be broken down into three stages: initiation, 
elongation, and termination, and the initiation stage is thought to be the rate limiting in 
the translation process. The messenger RNA (mRNA) is recognized by the 30S subunit 
and initiation factors aid in the recognition of the Shine-Dalgrano sequence in the mRNA. 
This allows for the proper orientation of the start codon and then the 50S subunit 
assembles forming the 70S particle. During elongation aminoacylated transfer RNA 
(tRNA) corresponding to the codon in the mRNA binds the ribosome at the A site. The 
aminoacyl group is released by the elongation factor EF-Tu and the tRNA is moved into 
the P site. Another aminoaceylated tRNA corresponding to the next codon in the mRNA 
binds to the free A site. This positions the tRNAs so that peptide bond formation occurs. 
The deacylated tRNA is then repositioned from the P site to the E site and is eventually 
pushed into the exit tunnel of the ribosome. When a stop codon enters the A site, release 
factors bind and induce release of the peptide chain from the P site (Kaczanowska and 
Ryden-Aulin, 2007). 
As nascent polypeptide chains emerge from the bacterial ribosome, they are 
greeted by two ribosome-bound chaperones, the signal recognition particle (SRP) and 
trigger factor (TF), and both bind the polypeptide chain co-translationally (Hoffmann et 
al., 2006). Proteins lacking signal sequences are recognized by TF, which can deliver the 
protein to another chaperone system such as GroEL (Kandror et al., 1995) or Hsp70 to 
assist in proper folding (Deuerling et al., 1999). Proteins containing signal sequences 
with long hydrophobic cores and transmembrane segments interact specifically with SRP 
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while TF binds less hydrophobic signal sequences to prevent SRP binding allowing for 
targeting the SecA post-translationally (Beck et al., 2000). A more in-depth description of 
SRP and SecA is presented in section 1.6.1. and 1.7., respectively. TF binds to stretches 
of eight amino acids that are enriched with basic and aromatic amino acids. The binding 
motif of TF is similar to the binding motif of another molecular chaperone, DnaK. Since 
these chaperones share a similar binding motif but are in different locations in the cell, 
they may be able to cooperate in protein folding (Deuerling and Bukau, 2004). The 
structure of TF revealed an unusual extended conformation that is made up of three 
domains (Figure 1.3, A). The ribosome-docking region is found in the N-terminal domain 
while the peptidyl-prolyl isomerase domain is at the other end of the structure. The C-
domain is sandwiched between the other two domains and forms the “arms” of TF 
(Hoffmann et al., 2006). When bound to the ribosome, TF is hunched over the 
polypeptide exit tunnel, which shields the nascent polypeptide and allows for TF to 
capture the chain in its hydrophobic cradle (Figure 1.3, B). The binding of TF may delay 
folding to allow for more of the chain to emerge from the ribosome so that the correct 
amount of sequence is present for folding (Deuerling and Bukau, 2004). 
In E. coli and many other Gram-negative bacteria, there is a dedicated secretion 
chaperone called SecB. There are several other molecular chaperones in bacteria such as 
GroEL, DnaJ, and DnaK but it is still unclear if these chaperones have any role in protein 
secretion. SecB can rapidly bind nascent chains still attached to the ribosome or to 
partially folded preproteins in the cytosol (van Wely et al., 2001). SecB associates and 
dissociates with polypeptide substrates without the use of ATP, which is in contrast to 
other chaperone such as GroEL and DnaK (Danese and Silhavy, 1998). The structural  
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Figure 1.3  Structure and function of trigger factor 
 
A. Crystal structure (1W26) of soluble trigger factor color-coded for the different 
domains: red, the N-terminal ribosome-docking region, yellow, the peptidyl-prolyl 
isomerase domain, and green, the C-terminal domain. B. Schematic representation of 
trigger factor bound at the exit tunnel of the ribosome. Adapted from Hoffmann et al. 
(Hoffmann et al., 2006). 
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organization of SecB is a homotetramer that is a dimer of dimers. There is a long channel 
located on both sides of the tetramer that is proposed to be involved in the binding of the 
polypeptide chain. This groove has two subsites with one deep cleft lined with aromatic 
residues and one shallow groove, which is hydrophobic in nature. The orientation of the 
two grooves allows the polypeptide to wrap around the SecB tetramer. The basis for how 
SecB differentiates between cytosolic and secretory proteins is still unclear since the 
binding motif is about nine amino acid in length and enriched in both aromatic and basic 
residues, which is very similar to other molecular chaperones. SecB keeps the preprotein 
in an unfolded state for translocation and targets the complex to the preprotein 
translocase SecA (Driessen and Nouwen, 2008).  
1.4. Secretory pathways in prokaryotes  
The secretion of proteins in bacteria is an intricate dance that requires specific 
recognition and delivery of the correct substrates to the proper translocation machinery. 
Bacterial cells have several different types of secretion systems including outer 
membrane systems (Saier, 2006). The development of distinct systems for general 
secretion, type II represented by the Sec and Tat pathways, enable cell survival while the 
more specialized systems, type I, III, and IV, are involved in pathogenesis. 
1.4.1. Type I, III, and IV secretion systems 
Gram-negative bacteria have developed specialized membrane secretion systems. 
The type I, type III, and type IV secretory pathways can export proteins across both the 
inner and outer membranes in one energy-coupled step. The type II secretory pathways 
cross only the cytoplasmic membrane. The type I ATP-binding cassette (ABC) 
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macromolecular system generally consists of two integral membrane domains and two 
cytoplasmic domains. This ABC transporter can associate with the main terminal branch 
(MTB) and outer membrane factor (OMF) proteins to enable secretion across both 
membranes. This system can transport ions, drugs, and proteins of various sizes including 
pathogens outside of the cell (Saier, 2006).  
Gram-negative pathogens have also developed two direct transport systems for 
the delivery of virulent proteins into the host organism to establish infection. The type III 
pathway assembles a needle complex and shares common ancestral relationship to the 
flagellar secretion system. The needle consists of a basal body structure that is assembled 
using the Sec pathway. This structure is followed by the needle filament assembly, which 
can interact with the host cell membrane and compromise its integrity. Once the needle 
has made contact with the host cell the virulent proteins are secreted into the host cell and 
begin to manipulate the host’s cellular processes (Cambronne and Roy, 2006). 
The type IV secretion system has some similarities to the type III system but is 
ancestrally related to the conjugation systems in bacteria. This secretion system also 
delivers into the cytosol of the host cell various virulent proteins, which modify the host 
cell’s physiology. The type IV system is made up of multiple subunits that span both the 
inner and outer membranes in Gram-negative bacteria. It is composed of a secretion 
channel and a surface filament or proteins (Christie et al., 2005). It is still unclear how the 
type IV system compromises the host cell membrane but it is likely that a small conduit 
could support the transport of the unfolded substrates (Cambronne and Roy, 2006). 
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1.4.2. Type II secretion systems 
1.4.2.1.Bacterial Sec pathway 
The general secretory (Sec) pathway is one of the main secretory pathways in 
prokaryotes (Gierasch, 1989). Signal sequences target proteins to this pathway by binding 
either co-translationally to the signal recognition particle (SRP) or post-translationally to 
SecA (Vrontou and Economou, 2004). Both of these pathways consist of four steps: 
recognizing the preprotein, maintaining the unfolded state, targeting to the translocon, 
and translocating across the membrane (Figure 1.1) (Clerico et al., 2008). The Sec 
pathway translocates proteins in the unfolded state, thus, allowing for protein insertion 
into the cytoplasmic membrane, folding in the periplasmic space, and secretion across or 
integration into the outer membrane. The majority of the components of the Sec system 
were identified by genetic studies in E. coli and this system contains three major 
components: a protein targeting unit, a motor protein, and a membrane embedded protein 
channel (Natale et al., 2008). In the SRP pathway, the signal sequence is recognized co-
translationally by SRP and the RNC complex is targeted to the SRP receptor (SR). The 
SRP/SR interaction delivers the RNC complex to the SecYEG translocon and continued 
translation of the polypeptide pushes it through the translocon. SecA, on the other hand, 
recognizes the signal sequence of the preprotein post-translationally. The molecular 
chaperone SecB keeps the preprotein in an unfolded conformation and brings it to SecA. 
SecA docks at the translocon and uses the energy generated from ATP hydrolysis to push 
the preprotein across the SecYEG translocon (Figure 1.1) (Clerico et al., 2008). In 
bacteria, the Sec pathway is responsible for the secretion of a majority of the extracellular 
proteins, which have a variety of functions needed for cell survival (Natale et al., 2008). 
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1.4.2.2.Tat pathway 
Another major secretory pathway in bacteria is the Twin-arginine translocation 
pathway, often referred to as the Tat pathway (Natale et al., 2008). The biggest difference 
between the Sec and the Tat pathways is that the Tat-pathway translocates properly 
folded secretory proteins across the cytoplasmic membrane (Figure 1.4, A). The secretory 
proteins are targeted to the Tat pathway by N-terminal signal sequences that are similar to 
Sec signal sequences. Tat signal sequence are composed of both n- and h-regions and in 
some cases a c-region that is cleavable. The recognition element of a Tat signal sequence 
is the almost invariant twin-arginine motif at the n-and h-region interface. In general the 
motif pattern is Z-R-R-x-φ−φ where Z is any polar residue and φ is any hydrophobic 
residue. Additionally, a Tat signal sequence often contains a positive residue in the c-
region to ensure that the substrate does not target to the Sec pathway. Many of the Tat 
substrates have cofactors added before translocation. Therefore, the Tat system is utilized 
to translocate proteins of redox pathways, anaerobic respiration, and the global nitrogen 
cycle (Natale et al., 2008) as well as for the establishment of infections in both plants and 
animals (Lee et al., 2006). Some Tat substrates do not contain cofactors and may have 
specific folding reasons for utilizing this pathway. The Tat translocase consists of TatA 
and TatC or TatA, TatB, and TatC, which are all integrated membrane proteins (Natale et 
al., 2008). Protein that are transported by the Tat pathway are involved in several cellular 
functions that are essential to the survival of the cell (Lee et al., 2006). 
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Figure 1.4  The Tat and YidC secretion pathways 
 
A. Model of the targeting and transport in the Tat pathway. Embedded in the membrane 
is the SecYEG translocon in green, TatA in red, TatB in blue, and TatC in yellow. (1) 
The nascent polypeptide chain emerging from the ribosome avoids targeting to the Sec 
pathway by the presence of the twin Arg (RR) residues. (2) The preprotein folds into the 
its final conformation and associates with any needed cofactors and/or additional subunits 
before targeting to the TatBC receptor complex (3). (4) The formation of the complete 
translocase is driven by the proton motive force. The folded preprotein is transported 
through the pore, which is formed predominately by TatA. (5) The signal sequence is 
removed and the mature protein is released into the periplasm. Adapted from Lee et al. 
(Lee et al., 2006). B. Model for YidC interaction with TM segments. The transmembrane 
(TM) segment of the protein leaves the SecYEG channel and associates with YidC. The 
first TM helix is released into the lipid membrane and the next TM segment binds YidC. 
YidC enables the integration of the TM segments during the translocation process. 
Adapted from Xie and Dalbey (Xie and Dalbey, 2008). 
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1.4.2.3.YidC 
YidC is another translocase that is found in bacteria (Scotti et al., 2000) and 
organelles of bacterial origin such as the mitochondria (Hell et al., 2001). This protein 
can act as an independent insertase to insert proteins into the cytoplasmic membrane 
(Scotti et al., 2000). In addition to its own independent function, YidC can also cooperate 
with the Sec pathway machinery to aid in membrane protein insertion (Veenendaal et al., 
2004) The independent function of YidC was discovered by its depletion from the 
membrane. Once YidC is no longer present, the insertion of Sec-independent proteins 
was inhibited (Samuelson et al., 2000). As an insertase, YidC plays a crucial role with the 
F1F0 ATPase (van der Laan et al., 2004) and cytochrome bo3 oxidase (Stenberg et al., 
2007). The role of YidC in these membrane-bound enzymes is likely the insertion of one 
of the subunits for the F1F0 ATPase or insertion of part of the enzyme into the membrane 
for cytochrome bo3 oxidase (Figure 1.4, B) (Xie and Dalbey, 2008). Recently, a medium-
level resolution map of YidC was determined by electron cryomicroscopy and revealed 
that YidC can form dimers in membranes (Lotz et al., 2008). It was proposed from this 
structure that the nature of the dimer interface could indicate the pathway, either Sec-
dependent or Sec-independent, for insertion of membrane proteins. YidC may act as a 
monomer in the complex with SecYEG but act as a dimer for independent insertion of 
proteins.  
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1.5. Secretory pathways in eukaryotes 
Although prokaryotes and eukaryotes are very different, they still share a similar 
co-translationally preprotein targeting system, SRP but have evolved different post-
translational systems. Organelles of prokaryotic origin have import machinery that is 
different from the plasma membrane export machinery in prokaryotes indicating that 
these organelles have evolved their translocation machinery. 
1.5.1. Eukaryotic Sec pathway 
In eukaryotic cells, protein secretion and membrane integration of proteins is 
more complicated than in bacteria due to the presence of membrane-bound organelles 
such as: nucleus, endoplasmic reticulum (ER), golgi apparatus, lysosome, endosome, 
peroxisome, mitochondria, and chloroplast. Most of the polypeptides are initially targeted 
to the ER for modification and folding before being sorted to their final destination 
(Alder and Johnson, 2004). The preprotein must translocate across the ER membrane 
from the cytosol where it was translated by the ribosome. In co-translational 
translocation, the RNC complex is recognized by the SRP and is similar to the system 
found in prokaryotes. The SRP/RNC complex is targeted to the SRP receptor (SR) at the 
ER membrane. This directs an interaction between the ribosome and the Sec61 translocon 
embedded in the ER membrane. The elongating nascent polypeptide chain associates 
with the translocon and the continued translation of the polypeptide translocates the 
preprotein through the channel (Figure 1.1) (Rapoport, 2008). 
Another subset of proteins is translocated post-translationally in eukaryotes but 
this is different from the bacterial SecA system. This post-translational translocation 
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involves the Sec61 translocon associating with the Sec62/63 protein complex. Initial 
recognition of the preprotein is mediated by Sec62/63, which subsequently transfers the 
preprotein to Sec61 (Schnell and Hebert, 2003). The translocation of the preprotein, at 
least in yeast, occurs through a ratcheting mechanism by interactions between the 
preprotein, Sec62/63, and BiP, an ER luminal Hsp70 chaperone. After a transient 
interaction with Sec63, BiP hydrolyzes ATP and closes its peptide-binding pocket on the 
translocation substrate. This prevents any backward sliding into the cytosol by the 
preprotein and enables forward movement into the ER lumen. After additional segments 
of preprotein enter the ER, another BiP molecule binds and the process is repeated until 
the entire preprotein has been translocated. Once ADP is exchanged for ATP, the BiP 
molecule is released from the translocated substrate (Rapoport, 2008). 
1.5.2. Protein import into mitochondria and chloroplasts 
Both mitochondria and chloroplast contain multiple membranes, which likely 
arose from an endosymbiotic relationship with prokaryotes. During the evolution, almost 
all of the genes from the endosymbiotic prokaryote were transferred to the nucleus of the 
host cell (von Braun and Schleiff, 2007). As a consequence N-terminal presequences or 
transit peptides are needed to target these proteins back to the correct organelle. 
Therefore, mitochondria and chloroplasts possess numerous translocons to translocate 
preproteins to the outer membrane, inner membrane, intermembrane space, and the 
internal soluble compartments (Schnell and Hebert, 2003). 
The presequence of a mitochondrial protein directs it to the translocon of the 
mitochondrial outer membrane (TOM) (Figure 1.5, A). Tom20 and Tom22 act as the 
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receptor domains while Tom40 forms the channel. Tom40 is not only a channel but also 
recognizes the preproteins and aids in the sorting of preproteins to the correct 
compartment. The TOM complex is used for the import of all preproteins across the outer 
membrane (Kutik et al., 2007). Preproteins destined for the mitochondrial matrix or inner 
membrane are directed to the translocon of the mitochondrial inner membrane (TIM). 
There are two TIM translocons in mitochondria. One, Tim23, is predominately 
responsible for the translocation of matrix proteins and a subset of integral membrane 
proteins containing a single membrane-spanning domain (Schnell and Hebert, 2003). 
This translocation process needs the assistance of the presequence translocase-associated 
motor (PAM). Small proteins destined for the intermembrane space (IMS) are imported 
into the IMS by the mitochondrial intermembrane space assembly machinery (MIA). The 
outer membrane β-barrel preproteins are imported by TOM and transferred by 
chaperones to the sorting and assembly machinery (SAM). The proteins of the inner 
membrane translocate through TOM and are transferred to the other mitochondrial 
translocon, Tim22, for insertion into the membrane (Kutik et al., 2007).  
The translocon of the outer membrane of the chloroplast (TOC) has three core 
components, Toc159, Toc34, and Toc75 (Figure 1.5, B). Toc159 and Toc34 are GTP-
binding proteins located at the chloroplast surface and interact with the preprotein at the 
beginning of the import process while Toc75, which likely forms a β-barrel structure, 
constitutes the channel protein. Toc 159 is the primary receptor for preproteins and works 
with Toc75 to translocate preproteins across the chloroplast outer membrane. Most of the 
outer membrane proteins actually lack a transit peptide and are targeted by signals within 
their membrane anchor. Preprotein transport across the outer membrane requires both  
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Figure 1.5  Protein import pathways in mitochondria and chloroplast 
 
A. Most mitochondrial proteins are synthesized in the cytosol by ribosomes and imported 
through the TOM complex. Matrix proteins containing presequences are transported by 
the TIM23 complex in conjunction with the motor protein PAM into the matrix. The 
mitochondrial processing peptidase (MPP) removes the presequence. The IMS small 
proteins are imported using the mitochondrial intermembrane space assembly machinery 
(MIA). Outer membrane (OM) precursors are transferred from TOM to SAM by Tim9-
Tim10 chaperone. Inner membrane (IM) precursors are transferred to the TIM22 complex 
by Tim9-Tim10. TIM22 drives the insertion of these IM proteins into the inner 
membrane. Figure adapted from Kutik et al. (Kutik et al., 2007). B. Core components of 
the chloroplast import pathway are shown in color. After translation by the ribosomes, 
preproteins are transported across the TOC complex, which consists of Toc159 and 
Toc34 as the receptors and Toc75 as the channel. Some preproteins are guided to the 
TOC complex by 14-3-3 protein and a Hsp70 chaperone. After translocation across the 
outer membrane, the preproteins interact with Hsp70 in the intermembrane space, which 
guides the preprotein to the TIC complex with assistance from Tic22. The TOC and TIC 
complexes associate and the preprotein crosses both membranes. The channel has been 
proposed to be formed by Tic110 and Tic20. The chaperones Cpn60 and Hsp93 help 
Tic40 fold the imported proteins. The transit peptide is cleaved from the preprotein by the 
stromal processing peptidase (SPP). Figure adapted from Kessler and Schnell (Kessler 
and Schnell, 2006). 
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ATP and GTP. Therefore, a Hsp70 has been proposed to function as the driving force for 
translocation while the Toc GTPases act as the regulators and receptors during initiation 
of translocation. The inner membrane translocon complex, the Tic components, has not 
been isolated in stoichiometric amounts. The Toc and Tic components begin to physically 
interact with each other during the early stages of translocation. This suggests that the 
inner membrane translocon is assembled in response to early interactions with Toc 
translocon. Two proteins form the proposed channel components for the inner membrane 
translocon, Tic110 and Tic20. It has been suggested that Tic110 is the docking site for 
the preproteins while Tic20 likely forms the membrane channel and is distantly related to 
channels of the mitochondrial inner membrane. Tic110 also associates with the molecular 
chaperones in the stroma and these chaperones provide the driving force the preprotein 
translocation across the inner membrane (Kessler and Schnell, 2006). 
1.6. Protein targeting and translocation in bacteria 
1.6.1. SRP 
The signal recognition particle is a ribonucleoprotein, which is found in all three 
kingdoms of life. SRP was first identified in mammalian cells and later in prokaryotic 
cells. The E. coli SRP is one of the simplest of the SRPs because it consists of only one 
protein, called Ffh for fifty-four homolog due to its homology to the mammalian SRP54 
protein, and a 4.5S RNA (Luirink et al., 2005). The Ffh component of the E. coli SRP is 
responsible for the binding of signal sequences. Ffh is made of three domains, the N 
domain, which interacts with the ribosome, the G domain, which has a GTP binding site 
and is also involved in binding SR, and the M domain, which has a high Met content and 
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interacts with the RNA (Clerico et al., 2008). The signal sequence likely binds to the M 
domain but also shows interaction with the NG domain (Cleverley and Gierasch, 2002). 
Unlike its mammalian counterparts, which target both secretory, and membrane proteins 
to the ER, E. coli SRP is predominantly involved with the translocation of inner 
membrane proteins. SRP actually interacts with the ribosome near the exit tunnel and 
binds to the signal sequences of integral membrane proteins (Figure 1.1). The SRP targets 
the RNC complex to the SR in the plasma membrane. The interaction between SRP and 
SR mutually stimulates each other’s GTPase activity and the RNC complex is transferred 
to the adjacent SecYEG translocon. The GDP-bound SRP is released from the complex 
so it can start another cycle (Clerico et al., 2008). 
1.6.2. SecA 
SecA is a preprotein translocase found primarily in bacteria but is also found in 
organelles of prokaryotic origin such as the chloroplast. Not only do bacterial SecA 
recognize and many different secretory proteins but it also acts as a processive motor to 
translocate preproteins across the inner membrane (Clerico et al., 2008). After translation 
and release from the ribosome, secretory proteins are held in the unfolded state by the 
molecular chaperone SecB. This new complex of the preprotein/SecB is targeted to SecA 
either in the cytosol or at the membrane. SecA recognizes and binds the signal sequence, 
a mature region of the preprotein, and SecB. SecA also interacts with both the SecYEG 
translocon through specific interactions with SecY and the inner membrane. These 
interactions induce a dramatic conformational change in SecA, which results in the 
release of the chaperone SecB. Using the energy from ATP hydrolysis as well as the 
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proton motive force, SecA undergoes further conformational gymnastics to translocate 
the preprotein across the inner membrane through multiple rounds of binding and release 
of the mature portions of the preprotein. Once the preprotein has been completely 
translocated, SecA is released and can begin another translocation cycle. (Driessen et al., 
2001). A more in-depth description of SecA is presented in section 1.7.  
1.6.3. SecYEG Translocon 
The bacterial translocon is a heterotrimeric membrane channel composed of three 
proteins, SecYEG, while the eukaryotic counterpart to the channel is called Sec61 and is 
made from the α, β, and γ subunits. In prokaryotes the largest of the subunits, SecY, is 
the core component and has ten transmembrane regions (TM1-TM10), six cytoplasmic 
regions (C1-C6), and five periplasmic/luminal loops (P1-P5). SecE is a small membrane 
protein and has three transmembrane domains in which only one makes extensive 
contacts with SecY. SecG has two transmembrane domains (Collinson, 2005). The first 
crystal structure of the channel was solved at 3.2 Å and represents the closed channel. 
This SecYEβ structure was from the archaeabacterium Methanococcus jannaschii and 
showed that SecY has two domains TM1-TM5 and TM6-TM10 that have an inverted 
pseudo-symmetry (Figure 1.6) (Van den Berg et al., 2004). This structure suggests that 
one copy of SecY forms the channel pore and this is supported by mutations that 
compensate for defective signal mapping to the center of the SecY complex. The central 
pore is blocked on the extracytoplasmic side by the presence of a small helix called the 
plug, which is part of SecY transmembrane helix 2. In order for substrates to translocate 
across the membrane the plug is required to move out of the way. The shape of the  
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Figure 1.6  The SecYEG translocon 
 
A. Side view of the SecY complex. The plug shown in green from helix 2a is held in the 
‘plug-hole’ in the closed complex. Adapted from Collinson (Collinson, 2005). B. The 
crystal structure of M. jannaschii SecY complex (1RH5) seen from the cytoplasm. The 
plug shown in green blocks the pore in the closed conformation. Transmembrane (TM) 1-
5 are in blue and TM 6-10 are in red. The bright blue helix is TM2b and SecE and Secβ 
are shown in gray. Adapted from Osborne et al. (Osborne et al., 2005). 
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channel is a hourglass lined with hydrophilic residues on both sides of the constriction 
point while at the point of constriction is several hydrophobic residues. This would 
provide a seal so that ions and other small molecules could not diffuse across the 
membrane during protein translocation. The pore must also widen to enable the passage 
of an unfolded polypeptide chain (Osborne et al., 2005). 
In another study using single particle cryo-electron microscopy, the structure of a 
translocating ribosome bound to SecYEG was solved and contained two SecYEG 
complexes. In this structure, only structural features of 10 Å were observed. The 
orientation of the two SecYEG complexes was front-to-front where the lateral gates from 
the protomers face each other but do not form a larger channel (Mitra et al., 2005). 
Several lines of evidence suggest that SecYEG can exist in different oligomeric states but 
this oligomerization does not appear to significantly change the conformation of the 
heterotrimer. Another possibility is that translocation partners, such as SecA and the 
ribosomes, could modulate the oligomeric state of SecYEG (Rusch and Kendall, 2007). 
Recently, two new crystal structures of the translocon were solved (Tsukazaki et 
al., 2008; Zimmer et al., 2008). SecYE from Thermus thermophilus bound to an anti-
SecY Fab fragment was resolved to 3.2 Å resolution (Tsukazaki et al., 2008). Overall, 
this structural architecture was similar to the original M. jannaschii SecYEβ structure 
(Van den Berg et al., 2004) but the TM6-TM10 region has been altered creating a small 
opening and has been termed the ‘pre-open’ state. In a low-resolution structure of SecYE 
without the Fab fragment, the structure was similar to the closed form like the SecYEβ 
structure. The anti-SecY Fab fragment binds to a motif in C5 that is the same region 
where SecA has been demonstrated to bind. These structures suggest that the closed form 
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of SecYE is energetically favored when no interacting components are present but the 
‘pre-open’ form is a conformation state induced by the binding of a ligand such as SecA 
(Tsukazaki et al., 2008).  
The second crystal structure solved was of Thermotoga maritima SecYEG bound 
to Thermotoga maritima SecA, without its carboxyl-terminal domain. This four-protein 
structure was fitted to a 4.5 Å model. The N-terminal residues of SecY, SecE, and SecG, 
C-terminal residues of SecY and SecG, as well as the periplasmic loop between TM1 and 
TM2a of SecY were not resolved. The SecA-SecYEG complex was strongest in the 
presence of ADP-BeFx AlFx, which mimics the intermediate states during ATP hydrolysis 
(Zimmer et al., 2008). Both of these structures likely represent the early stages of 
preprotein translocation. 
1.7. Preprotein translocase SecA 
SecA was discovered in the early 1980’s through genetic work. This protein plays 
a central role in the bacterial Sec pathway. SecA is only found in prokaryotes and 
organelles of prokaryotic origin such as the chloroplast. Like SRP, SecA selectively binds 
signal sequences of preproteins but recognizes them post-translationally and most of the 
preproteins are destined for the periplasm, the outer membrane, or extracellular secretion. 
In addition to signal sequence recognition, SecA also acts as a processive motor to 
translocate proteins across the inner membrane (Clerico et al., 2008). 
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1.7.1. SecA interaction partners 
1.7.1.1.SecA dimerization 
SecA is a large protein that interacts with several different ligands during the 
preprotein translocation reaction (Figure 1.7). This preprotein translocase is a 102 kD 
protein and in solution forms homodimers with a monomer-dimer equilibrium of 0.25 – 
0.5 µM depending on protein concentration, salt concentration, temperature, and ligands 
(Woodbury et al., 2002). The bacterial cellular concentration of SecA is 5 µM suggesting 
that it is mostly in the dimeric form. However, studies have shown that SecA may 
function as a monomer during the translocation cycle (Or et al., 2005; Or and Rapoport, 
2007; Duong, 2003) while other studies indicate that the SecA dimer stay intact during 
translocation (Jilaveanu et al., 2005; de Keyzer et al., 2005; Wang et al., 2008). A recent 
crystal structure of SecA bound to the SecYEG translocon indicates that SecA likely acts 
as a monomer during the translocation reaction (Zimmer et al., 2008). 
1.7.1.2.ATP binding and hydrolysis 
SecA is a processive motor enzyme that uses ATP hydrolysis to push preproteins 
through the SecYEG channel. Initial studies suggested two distinct ATP binding sites 
were available on SecA (Mitchell and Oliver, 1993; van der Wolk et al., 1995; den 
Blaauwen et al., 1996; van der Wolk et al., 1997; Miller et al., 2002). The first crystal 
structure of SecA showed that only one ATP binding site was present on SecA. The ADP 
or ATP binds SecA at the interface between nucleotide binding fold I (NBF I) and 
nucleotide binding fold II (NBF II) and stabilizes the SecA molecule in a compact 
conformation. The nucleotide binding folds share structural homology with DEAD-box 
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Figure 1.7  SecA interacts with several ligands 
 
SecA crystal structure (1M6N) color-coded for the different domains: blue, NBF I; 
purple, NBF II; yellow, PPXD; green, HSD; orange, HWD; and red, CTL (see Figure 1.8 
more structural details).  The nucleotide binding site has been precisely mapped but the 
other ligand binding sites are less clear. SecAβ indicates the second SecA protomer. 
Adapted from Vrontou and Economou (Vrontou and Economou, 2004). 
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helicases. The nucleotide binding site is formed by the helicase motifs. The Walker A 
consensus sequence binds the α- and β-phosphates of the nucleotide by forming a P-loop 
helix-capping structure. The Walker B consensus sequence is a hydrophobic β-strand 
ending in an Asp residue, which contacts the Mg+2 cofactor. The Glu from the DEAD-
box is the likely candidate for the catalytic base in the ATP hydrolysis reaction (Hunt et 
al., 2002). 
A subsequent study using NMR, thermodynamic, and biochemical techniques 
demonstrated that the regions lining the nucleotide binding cleft undergo transitions 
between disordered and ordered states that correspond to the functional catalytic states 
(Keramisanou et al., 2006). This disordered region was also previously observed in our 
lab by NMR (Chou et al., 2002). Furthermore, Arg 574 and Arg 509, both found in the 
helicase motifs, are important in enhancing the catalytic activity of SecA (Keramisanou 
et al., 2006). 
During the translocation cycle, SecA goes from a low basal ATPase rate to eight-
fold higher translocation ATPase rate (Vrontou et al., 2004). Truncation of the C-terminal 
one-third of SecA causes an unregulated, hyperactive ATPase rate (Karamanou et al., 
1999; Triplett et al., 2001). Deletion of the intramolecular regulator of ATP hydrolysis 1 
(IRA1) also causes the unregulated ATPase activity of SecA. In the closed and compact 
cytosolic form of SecA, IRA1 suppresses the ATPase rate of SecA but upon interaction 
with the membrane or the translocon, IRA1 is released and the ATPase rate of SecA is 
dramatically increased to help facilitate the translocation of the preprotein across the 
inner membrane (Karamanou et al., 1999). 
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1.7.1.3.SecB interactions 
In order for preproteins to be translocated across the inner membrane post-
translationally by SecA in Gram-negative bacteria, the molecular chaperone SecB 
recognizes and binds preproteins to keep them in an unfolded state. SecB can then target 
them to the preprotein translocase SecA. SecB has a high affinity for the membrane-
bound form of SecA (KD = 10-30 nM) (Vrontou and Economou, 2004). SecB is a 
homotetramer and has three potential areas of interaction with SecA. One of the contact 
regions is between the negatively charge surface formed by each dimer of SecB and the 
zinc-binding domain at the extreme C-terminus of SecA. A second area involves the C-
terminus of SecB and the interfacial region of the dimer (Patel et al., 2006) of SecA from 
the B. subtilis structure (Hunt et al., 2002). The third area of interaction was discovered 
by truncation of both SecA and SecB, which eliminated the other binding interactions. 
This third interaction may not be stable enough to maintain association on its own. Even 
though SecB is a tetramer and SecA is a dimer, the complex formed is asymmetric which 
may have implication for preprotein translocation (Patel et al., 2006). 
1.7.1.4.SecYEG binding 
Several years ago it was shown that SecA interacts with the SecYEG channel, and 
SecA was proposed to insert into the channel with the preprotein (Economou and 
Wickner, 1994). Only recently have the molecular details of the SecA-SecY interaction 
begun to be understood. Several indirect methods have been used to assess the SecA-
SecYEG interactions (Snyders et al., 1997; van der Sluis et al., 2006; Karamanou et al., 
2008) but they have not provided conclusive evidence.  
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Using an in-vivo site-directed cross-linking technique, Mori and Ito (Mori and Ito, 
2006a) studied the SecA-SecY interaction by the incorporation of the photoactivatable 
cross-linker in the cytoplasmic loops of SecY. Cross-linking was observed with SecA to 
the C2, C4, C5, and C6 loops of SecY. The presence of NaN3, a known powerful 
inhibitor of SecA translocation activity, enhanced cross-linking to C6 suggesting that this 
interaction is likely to be dynamic during the translocation reaction. The interactions with 
C2, C4, and C5 are more static in nature and the C5 loop appears to be involved in the 
binding of the N-terminal two-thirds of SecA (Mori and Ito, 2006a). The C5 residue Arg 
357 was subsequently shown to be essential for the initiation of the translocation cycle by 
SecA (de Keyzer et al., 2007). 
The interaction sites proposed by Mori and Ito (Mori and Ito, 2006a) were used to 
design disulfide cross-linking experiments with SecA. Cys substitutions were made in the 
C6 loop of SecY and the NBF I of SecA. The cross-links mapped one face of the NBF I 
to the tip of the C6 loop of SecY. In another experiment, two linked SecY proteins were 
used for cross-linking with SecA and a preprotein. The results indicated that one SecY 
channel interacted with the preprotein while the second one bound the NBFI of SecA. 
This suggests that SecYEG can function as a dimer with one active translocon for 
preproteins and a second translocon for binding SecA (Osborne and Rapoport, 2007). 
The structure of SecA bound to the SecYEG translocon has recently been solved 
at 4.5 Å. This structure demonstrates that both SecA and the SecY complex undergo large 
conformational changes upon binding. In this structure only one SecA molecule is bound 
to one copy of the SecY channel. The majority of the interactions are made by the 
preprotein cross-linking domain (PPXD) of SecA and the loops connection TMs 8-9 and 
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TMs 6-7 of SecY. Additionally, the α-helical scaffold domain (HSD) makes extensive 
interactions with SecY. Other minor interactions occur as well but these have small 
contact surfaces and likely could not sustain the interaction alone. To correlate this 
structure (Zimmer et al., 2008) with the previous disulfide cross-linking results (Osborne 
and Rapoport, 2007), it was proposed that this new structure represents the active channel 
through which preproteins are translocated. The inactive channel that interacts with the 
NBF I was lost during detergent solubilization (Zimmer et al., 2008). Clearly, the SecA-
SecY interaction is important in the translocation of preproteins and we are just 
beginning to understand some of the molecular details of this dynamic interaction. 
1.7.1.5.Interactions with phospholipids 
In addition to its interactions with other components of the secretory pathway, 
SecA can also interact and insert into the inner membrane. Protease protection assays in 
the presence of inverted membrane vesicles, ATP, and preproteins, demonstrated that a 
30 kD fragment of SecA is protected from the protease. N-terminal sequencing revealed 
that this protected fragment started at residue 610 indicating that the 30 kD fragment is 
composed of the C-terminal third of the protein (Price et al., 1996). 
Other experiments have demonstrated that long-chain phospholipids analogues 
cause SecA to monomerize. In addition to the change in oligomeric state, the 
phospholipids also cause domain dissociation in SecA (Benach et al., 2003). Acidic 
phospholipids are required for efficient translocation of preproteins by SecA. 
Fluorescence experiments with SecA and labeled phospholipids revealed that SecA can 
penetrate deep into the phospholipids bilayer. This also induces a partial unfolding or 
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domain dissociation of SecA that could be important for the translocation cycle (Ulbrandt 
et al., 1992). 
1.7.1.6.Preprotein binding 
The major function of SecA is the translocation of preproteins across the inner 
membrane. The preprotein consists of two parts, the signal sequence and the mature 
region and SecA interacts with both of these parts. Signal sequences can bind to SecA in 
solution as well as in the presence of liposomes (Vrontou and Economou, 2004). Several 
different regions in the N-terminal two-thirds of SecA have been proposed as the signal 
sequence-binding site in soluble SecA (Kimura et al., 1991; Triplett et al., 2001; Hunt et 
al., 2002; Baud et al., 2002; Chou and Gierasch, 2005; Papanikou et al., 2005; Gelis et 
al., 2007)  as well as SecA bound to liposomes (Musial-Siwek et al., 2005; Musial-Siwek 
et al., 2007). Most of these observation or predictions have been made on the soluble 
form of SecA, which may not be the physiologically relevant form of SecA to study 
signal sequence interactions (Clerico et al., 2008). Another study indicated that the 
nucleotide state of SecA can modulate the affinity of the signal sequence (Shin et al., 
2006). The recognition and binding of the mature portion of the preprotein is still poorly 
understood. The binding site for the mature regions of the preprotein should have some 
fundamental characteristics such as: binding to 20-30 amino acids at a time, no sequence 
specificity, and a small bound versus unbound energy barrier (Vrontou and Economou, 
2004). One study demonstrated that the mature portion of a preprotein could interact with 
the PPXD of SecA (Papanikou et al., 2005). Despite several years of research effort and 
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the central importance of this question, preprotein interactions with SecA are still not 
clearly understood. 
1.7.2. SecA crystal structures 
The first crystal structure of dimeric SecA from Bacillus subtilis revealed the 
structural architecture of the monomer, which consists of five different domains (Figure 
1.8, A). The catalytic activity of ATP hydrolysis is carried out by the first nucleotide 
binding fold (NBF I) in blue and the second nucleotide binding fold (NBF II) in purple. 
These two domains have a ′RecA-like′ fold which creates the nucleotide binding site at 
the interface between the domains. Additionally, NBF I and II share structural homology 
with the superfamilies I and II ATP-dependent helicases. A unique domain in SecA is the 
preprotein cross-linking domain (PPXD) in yellow, which interrupts NBF I (Hunt et al., 
2002) and has been demonstrated to bind preproteins (Vrontou and Economou, 2004; 
Papanikou et al., 2005). The α-helical scaffold domain (HSD) in green follows the NBF 
II and has been implicated as the conformational regulator of SecA (Mori and Ito, 
2006b). The α-helical wing domain (HWD) in orange interrupts the HSD and can loosely 
pack against the PPXD but the function of this domain has not been determined. The 
carboxyl-terminal linker (CTL) in red at the C-terminus of the protein contains the zinc 
binding motif and has also been shown to interact with phospholipids as well as SecB. 
The last 40 residues at the extreme C-terminus were not resolved in the B. subtilis 
structure (Hunt et al., 2002) or any of the subsequent crystal structures. 
The only structure of the extreme C-terminus of SecA is a solution NMR structure 
of the last 22 residues that includes the zinc binding motif (Dempsey et al., 2004). The  
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Figure 1.8  Different structures of SecA 
 
Three different crystal structures of SecA demonstrate that the overall domain 
organization is similar but the preprotein cross-linking domain has three different 
orientations. A. The B. subtilis structure (1M6N) has the PPXD in a closed form with 
intramolecular interactions with the HWD. The last 40 residues are missing from this 
structure Hunt et al., 2002). B. The NMR structure of E. coli SecA (2VDA) shows that 
the PPXD has rotated away from the HWD and is in the open conformation. This 
structure is missing the most of the CTL (Gelis et al., 2007). C. SecA structure from T. 
maritima bound to the SecYEG translocon (3DIN). The translocon is not shown for 
clarity. The PPXD has moved even further away from the HWD and has some 
intramolecular interactions with NBF II. The CTL of SecA is missing from this structure 
(Zimmer et al., 2008). D. Linear representation of SecA color-coded for the different 
domains. The sequence numbering beneath the cartoon is for E. coli SecA. 
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zinc is coordinated by three Cys and one His residues in the CXCXSGX8CH sequence. 
The conserved Ser forms a strong hydrogen bond with the third Cys. This interaction 
likely plays an important role in the stability of the structure. This zinc binding domain is 
a key player in the interaction between SecA and SecB.  
Other dimeric crystal structures of SecA from various prokaryotes species have 
been reported (Sharma et al., 2003; Zimmer et al., 2006; Vassylyev et al., 2006; 
Papanikolau et al., 2007) as well as a monomeric B. subtilis SecA structure (Osborne et 
al., 2004) All of these structures have similar monomer architecture except for the 
interface of the PPXD and HWD. In some structures the PPXD loosely packs against the 
HWD in the so called ‘closed’ state (Figure 1.8, A) (Hunt et al., 2002; Sharma et al., 
2003; Zimmer et al., 2006; Vassylyev et al., 2006) while in other structures the PPXD 
rotates about 60° and is no longer in contact with the HWD in a so called ‘open’ state 
(Figure 1.8, B) (Papanikolau et al., 2007; Osborne et al., 2004). A recent elegant NMR 
structure of full-length Escherichia coli SecA demonstrated that SecA visits both the 
‘open’ and ‘closed’ conformations in solution but the major species is the ‘open’ state 
(Gelis et al., 2007). The previously mentioned structure of SecA bound to the SecYEG 
translocon shows that SecA undergoes another conformational change upon binding to 
the translocon (Zimmer et al., 2008). The overall architecture remains the same but the 
PPXD has rotated even further away from the HWD and interacts with both NBF II and 
SecY. Another difference is the relative positions of the two NBFs. This structure was 
solved with ADP-BeFx, which mimics transition state during ATP hydrolysis and shows 
that NBF II has a rigid body rotation of about 15º towards the plane of the membrane. 
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This positions Arg 574 (E. coli numbering) towards the γ-phosphate of the ATP to trigger 
the hydrolysis reaction. Although these structures have started to provide atomic 
resolution snapshots of SecA but none of these structures provide full mechanistic details 
about SecA in its activated state prior to and during translocation. 
1.7.3. Different conformations of SecA 
In order for SecA to perform its required function as a preprotein translocase, it 
must perform conformational gymnastics. In the cytosol, SecA exists in ‘closed’ dimeric 
form and is protease resistant. Intramolecular interactions between the different domains 
help stabilize this compact conformation. Binding of different ligands such as SecB, 
phospholipids, and SecYEG trigger domain dissociation in SecA by weakening the 
intramolecular interactions to different extents. This domain dissociation results in a more 
open structure that is protease sensitive (Clerico et al., 2008). The conformational 
changes of SecA will be further described in the introduction to Chapter 2.   
1.7.4. Signal sequence interactions with SecA 
In order to test the secondary structure hypothesis of signal sequences (Emr and 
Silhavy, 1983) with SecA, our group performed line broadening and transfer Nuclear 
Overhauser Effect (trNOE) NMR experiments using synthetic signal peptides and soluble 
SecA (Chou and Gierasch, 2005). The observed trNOEs demonstrated that signal peptide 
bound to SecA adopted an α-helical structure in the h- and c-regions. Differential line 
broadening experiments indicated that one side of the helix form from residues in the h-
region was more strongly bound to SecA. Additionally, the positive n-region of the signal 
sequence also contributed to the binding interaction. Therefore, the electrostatic and 
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hydrophobic characteristics as well as the secondary structure are needed for signal 
sequence-binding to SecA. 
A considerable amount of effort has been expended in trying to determine the 
signal sequence-binding site on SecA. Initial studies demonstrated that signal sequences 
interact with the N-terminal two-thirds of SecA (Kimura et al., 1991; Triplett et al., 2001) 
but further biochemical and biophysical experiments do not converge on one signal site 
(Figure 3.3 and for further description and discussion see the introduction to Chapter 3). 
Major conformational changes are induced in SecA after initial interaction with 
preprotein and SecB. Very few signal sequence-binding studies have been performed on 
this more open translocation-active form, which is likely to be more physiologically 
relevant. 
1.8. Statement of Dissertation 
Protein secretion across or insertion into biological membranes occurs in all three 
kingdoms of life. Approximately, one-third of a cell’s proteome is secretory and integral 
membrane proteins (Papanikou et al., 2007). Over the last three decades considerable 
work has been performed to understand the targeting of the secretory proteins to their 
subcellular compartments and their active transport across membranes. Though 
significant progress has been made, many of the mechanistic details are still unresolved. 
In particular, the recognition mechanism of diverse signal sequences still remains elusive. 
The studies of a truncated version of SecA, SecA64 (Triplett et al., 2001) and of 
the ATPase enhancement of SecA in denaturant (Song and Kim, 1997) lay the 
groundwork for this study. The SecA64 study demonstrated that the ATPase activated 
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form of SecA bound signal peptides better than the full-length protein (Triplett et al., 
2001) while the denaturant study showed that low concentrations of denaturant have a 
similar effect on the activation of the ATPase activity as SecA64 but in the context of the 
full-length protein (Song and Kim, 1997). In this current study, full-length SecA in the 
presence of low concentrations of urea was characterized for structural changes to 
understand the conformational rearrangements of the activated translocation-competent 
SecA. Furthermore, this work describes the interactions of signal peptides with the 
cytosolic (solution) form of SecA as well as the translocation-active conformation of 
SecA. 
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CHAPTER 2 
CHARACTERIZATION OF TRANSLOCATION-ACTIVE SECA 
2.1 Introduction 
SecA is a dynamic protein that visits different conformations during the 
preprotein translocation cycle. In the cytosol, SecA is in a closed form and has low 
ATPase activity (Schmidt et al., 2000). SecA can bind preproteins either in the cytosol or 
at the membrane. In the case of Gram-negative bacteria, the preprotein/SecB complex 
interacts with SecA already associated with the SecYEG translocon. These binding 
interactions with other components of the secretory pathway induce a major 
conformational change in SecA resulting in an open domain dissociated form (Clerico et 
al., 2008). This form of SecA possesses a high ATPase activity (Lill et al., 1990), which 
is used to help translocate the preprotein through the SecYEG channel.  
Oliver and Beckwith (Oliver and Beckwith, 1982) first described SecA as a 
peripheral inner membrane protein but a subsequent study demonstrated that SecA 
partitioned between the cytosol and the inner membrane (Cabelli et al., 1991), and further 
experiments indicated that SecA could insert into membrane vesicles (Ulbrandt et al., 
1992). Through protease-protection assays in membranes, Economou and Wickner 
(Economou and Wickner, 1994) showed that a 30 kD fragment corresponding to the C-
terminal one-third of SecA was protected upon interaction with membranes, and they 
concluded it was inserted into the membrane. The cytosolic or solution form of SecA has 
been studied by FRET analysis (Ding et al., 2003a) and cryo-electron microscopy, which 
demonstrated that soluble SecA is in a closed dimeric conformation (Chen et al., 2008). 
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Taken together these results clearly illustrate that SecA has at least two distinct 
conformations, the closed cytosolic form and open membrane-bound form (Figure 2.1). 
Studies performed on cytosolic SecA (c-SecA) have demonstrated that 
temperatures slightly higher than physiological temperature induced an endothermic 
conformational change (Schmidt et al., 2000; Fak et al., 2004). Using SecA mutants 
discovered through genetic analysis (Fikes and Bassford, 1989) (Fortin et al., 1990) 
(Oliver et al., 1990), Schmidt et al. (Schmidt et al., 2000) discovered at low temperatures 
these mutants are in the same open conformation as is wild-type SecA at elevated 
temperatures. These results suggest that the conformational changes observed at higher 
temperatures or because of physiologically relevant mutations change the conformation 
of SecA into a form similar to the membrane-bound form. 
Driessen and coworkers (den Blaauwen et al., 1996) studied the effects of 
different nucleotides on the conformation of cytosolic SecA (c-SecA). Trp fluorescence 
revealed that ADP induced a closed form of SecA and the binding of an ATP analog, 
AMP-PNP enabled SecA to adopt a more open conformation. This open conformation 
was caused by the loosening of interactions between the C-terminal one-third of SecA 
and the N-terminal region. These results suggest that a domain dissociation of the C-
terminal region of c-SecA upon AMP-PNP binding could aid in the priming of SecA for 
interaction with the membrane and/or SecYEG.  
In another study using fluorescence resonance energy transfer (FRET) (Ding et 
al., 2003b), the close proximity of the PPXD and the C-terminal one-third of SecA was 
examined. This study demonstrated that ADP promotes a tight association between the 
PPXD and HWD while higher temperature and binding to model membranes caused a  
  51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Different conformations of SecA 
 
SecA exists in at least two different conformations. In the cytosol SecA is in a closed 
ADP-bound form with low ATPase activity. Various ligands such as lipids, SecB, 
preprotein, and translocation as well as high temperature, denaturants, and truncation of 
the C-terminus force SecA to adopt the open conformation. Adapted from Fak et al. (Fak 
et al., 2004). 
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dissociation of the two domains. Furthermore, the hyperactive azide-resistant mutant of 
SecA (Oliver et al., 1990) is in an even more open conformation in the cytosolic form 
(Ding et al., 2003b). The recent NMR structure of SecA (Gelis et al., 2007) argued that c-
SecA visits both the open and closed state but is predominantly in the open state (Figure 
1.8, B). The NMR data on SecA was collected in the nucleotide-free form, which may 
have influenced the promotion of the open state. The recent structure of  truncated SecA 
bound to the SecYEG translocon solved by Rapoport and colleagues (Zimmer et al., 
2008) was determined in the presence of ADP BeF3-, a transition-state analog. As 
discussed in Chapter 1 section 1.7.2., this translocon-bound structure of SecA has the 
PPXD in an even more open conformation (Figure 1.8, C). All of these results suggest 
that the nucleotide bound to SecA influences PPXD and HWD dissociation and 
reorientation. 
To try to understand the conformational changes induced in SecA upon binding to 
model membranes, Oliver and co-workers (Ding et al., 2001) employed fluorescence 
experiments using SecA mutants containing single Trp substitutions to identify the 
residues involved in phospholipid binding. SecA contains seven Trp residues (349, 519, 
541, 622, 701, 723, and 775) (Figure 2.2) but Trp701, Trp723, and Trp775 located in the 
C-terminal portion of SecA are the major contributors to the overall fluorescence. In 
solution Trp723 and to a lesser extent Trp701 are solvent accessible while Trp775 is 
buried. In model membranes, Trp723 is less solvent exposed, Trp775 becomes more 
solvent exposed and Trp701 did not change in solvent accessibility. These results suggest 
that the C-terminal portion of SecA is flexible and therefore, may be crucial for the 
preprotein translocation cycle. 
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Figure 2.2 Seven Trp residues in SecA 
 
The NMR structure from E. coli (Gelis et al., 2007) (2VDA) illustrates the seven Trp 
residues shown in the cyan spheres in SecA. The linear cartoon below the structure is 
colored for the different domains in SecA and show the positions of each of the Trp 
residues by the cyan boxes. *Indicate the Trp residues that contribute most to the overall 
fluorescence in SecA (Ding et al., 2001). 
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Natale et al. (Natale et al., 2005) utilized fluorescence spectral changes in single 
Trp mutants of SecA along with acrylamide quenching to probe the structural 
rearrangements of SecA upon binding to the SecYEG translocon. The binding of SecA to 
the translocon induces SecA changes in the PPXD, NBF II and HWD. These results 
demonstrate that SecA bound to SecYEG adopts a conformation that is different from the 
cytosolic form and are observed in the recent truncated SecA/SecYEG structure (Zimmer 
et al., 2008). 
In another set of experiments using proteolysis and fluorescence of a fluorescein-
labeled SecY, SecA was observed to bind SecYEG in a protease-sensitive conformation 
independent of nucleotide. The fluorescence experiments indicated that additional 
conformational changes occur in the SecA/SecYEG complex upon ATP analog binding. 
This change in conformation is transmitted from the NBFs of SecA to the pore region of 
SecY. The studies suggest that there are several different conformational changes in the 
SecA/SecYEG complex during the preprotein translocation cycle (Robson et al., 2007). 
Despite many biochemical and biophysical studies, the conformational changes in 
SecA during the translocation cycle are still unclear due to the lack of a good stable 
model of the active state. Many of the previous studies have utilized only one technique 
such as fluorescence and have used modified or mutated SecA protein. This chapter 
describes the activation and conformational change of SecA in adopting the 
translocation-active form. We use low concentrations of urea to activate SecA by domain 
dissociation. Through various biophysical experiments, limited proteolysis, and domain 
mapping, we have characterized a physiologically relevant, soluble form of SecA that 
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reflects the functional conformation prior to preprotein translocation across the inner 
membrane. 
2.2 Results 
2.2.1. Activation of SecA in low concentrations of urea 
To generate an in vitro form of full-length SecA that represents the 
conformational change during the early stages of translocation, we followed up on the 
work of Song and Kim (Song and Kim, 1997), which demonstrated that the ATPase 
activity of SecA becomes uncoupled in low concentration of denaturant. We performed 
urea titrations to examine the ATPase activity of SecA at 22°C. As the concentration of 
urea increased, the ATPase activity of SecA was enhanced to a peak rate at 2.2 M urea 
(Figure 2.3). This is an eight-fold higher activity than SecA in 0 M urea. After this peak 
in activity, the ATPase activity drops sharply and by 2.8 M urea no ATPase activity is 
observed. This eight-fold activation of the ATPase activity of SecA in 2.2 M urea is 
similar to the activation during preprotein translocation (Papanikou et al., 2004). 
2.2.2. Structural analysis of intermediate 
2.2.2.1.Tryptophan Fluorescence 
The seven intrinsic Trp residues in SecA (Figure 2.2) provide us a tool to probe 
the tertiary structure of SecA during the course of a urea melt. The emission maximum of 
native SecA is 340 nm. Upon full denaturation in 8 M urea, the emission maximum red 
shifts to 350 nm and decreases in intensity (Figure 2.4, A). During a urea melt at 22ºC, 
SecA Trp fluorescence at 340 nm begins decreasing at 1.4 M urea and at 2.2 M urea  
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Figure 2.3 Low concentration of urea stimulate the ATPase activity of SecA 
 
The ATPase activity of SecA was measured as a function of urea concentration at 22ºC. 
A peak in activity is observed at 2.2 M urea followed by a sharp decrease to no activity. 
SecA in the absence of urea was set to 100% activity. The error bars represent the 
standard deviation from three separate experiments. 
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Figure 2.4 Changes in SecA tertiary structure 
  
A. The Trp fluorescence change in SecA upon unfolding in urea at 22ºC. The red circles 
show the Trp fluorescence of native SecA excited at 295 nm. Native SecA has an 
emission peak around 340 nm. The blue circles show unfolding SecA in 8 M urea. Upon 
unfolding the fluorescence signal decreases and red-shifts to about 350nm. B. The Trp 
fluorescence was normalized to SecA in the absence of urea. The urea melt of SecA at 
22ºC shows an intermediate from 2.5 to 3.4 M urea and SecA is fully unfolded by 4 M 
urea.  
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about 50% of Trp fluorescence is lost. The maximal ATPase activity of SecA is in 2.2 M 
urea. The fluorescence data suggests the presence of an intermediate in 2.2 M urea region 
of the melt. The fluorescence remains nearly constant from 2.5 M urea to 3.4 M urea and 
SecA completely unfolds around 4 M urea. Trp 701, 723, and 775 have been shown to 
contribute most to the overall Trp fluorescence of SecA (Ding et al., 2001). Both Trp 701 
and 723 are located in the HWD while Trp 775 is located in the C-terminal HSD. Trp775 
is the most solvent inaccessible of the three Trp residues so the intramolecular 
interactions holding the C-terminal HSD to the other domains has been disrupted has 
been disrupted in 2.2 M urea. Taken together these results suggest that the increased 
ATPase activity of SecA is occurring due to a conformational change/unfolding event in 
the C-terminus of SecA.  
2.2.2.2.Far-UV CD 
In order to gain further understanding of the structural changes that occur in 
SecA, we examined the far-UV CD spectra in several urea concentrations (Figure 2.5). 
Due to the presence of urea, spectra could only be recorded to 215 nm. The helical 
content of SecA decreases as the urea concentration is increased. SecA in 2.2 M urea has 
lost about 25% of its helical content (Figure 2.6, green diamonds). Additionally, a 
structured intermediate is likely since there is very little change in the helical content 
from 2.2 M urea to 3.0 M urea. This loss of helical structure is likely attributed to 
unfolding or domain rearrangement in the C-terminal portion of the protein, in particular 
part of the HSD and the HWD. 
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Figure 2.5 Secondary structural changes in SecA in urea 
 
The far-UV CD of SecA in different concentrations of urea at 22ºC shows a decrease in 
the helical content of SecA as the concentration of urea is increased. SecA in the cluster 
of the spectra from 2.2 M to 3.0 M urea indicate the presence of an intermediate. 
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Figure 2.6 Activity and structural changes of SecA in urea 
 
Low concentrations of urea activate the ATPase activity SecA. The red circles represent 
the percent of ATPase activity of SecA from Figure 2.3. The blue squares show the Trp 
fluorescence of SecA at 340 nm as shown in Figure 2.4. The green diamonds show the 
far-UV CD signal of SecA at 222 nm. The Trp and CD signal were normalized to SecA 
in the absence of urea. SecA in 2.2 M urea has an eight-fold enhancement in activity over 
SecA in 0 M urea and both the Trp fluorescence and far-UV CD indicate the presence of 
an intermediate at this urea concentration. 
  66 
 
 
 
 
 
 
 
 
 
 
 
 
  67 
 
When the ATPase activity, Trp fluorescence, and far-UV CD are plotted together 
(Figure 2.6), it is clear that the peak ATPase activity coincides with a structured 
intermediate at 2.2 M urea. We term this intermediate form of SecA u-SecA. 
2.2.2.3. Limited proteolysis 
To gain further insight into how u-SecA differs structurally from the c-SecA 
structure, we performed a time course of limited proteolysis on both forms of SecA using 
α-chymotrypsin (Figure 2.7). Strikingly, u-SecA is much more protease sensitive than c-
SecA indicating that u-SecA is in a domain dissociated conformation similar to what has 
been observed for SecA in the presences of phospholipids (Ulbrandt et al., 1992). 
Quantitation of the amount of full-length SecA at each point in the digestion shows that 
in c-SecA 40% of full-length SecA remains after 15 minutes of digestion while full-
length SecA in u-SecA is completely digested by five minutes (Figure 2.7, B). To further 
understand into the conformational change in u-SecA, we performed the chymotryptic 
digestion followed by detection with the region-specific antibodies developed by 
Ramamurthy and Oliver (Ramamurthy and Oliver, 1997) (Figure 2.8). These antibodies 
were generated before the first crystal structure of SecA was solved but the antibodies 
still roughly match the six different domains in SecA.  
The region-specific antibody detection shows that a portion of NBF I, the C-
terminal region including the HWD, the C-terminal HSD, and the CTL are the regions of 
the protein cleaved in both forms (Figure 2.9). These results are consistent with the 
fluorescence and near-UV CD suggesting that the C-terminal portion of the protein is  
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Figure 2.7 Limited proteolysis demonstrates u-SecA is in an open conformation 
 
A. A time course of limited proteolysis of c-SecA and u-SecA was analyzed by an 8% 
SDS-PAGE and stained with Coomassie blue. The lanes are as follows: (1) SecA no 
digestion, (2) c-SecA 10 sec, (3) u-SecA 10 sec, (4) c-SecA 1 min, (5) u-SecA 1 min, (6) 
c-SecA 2 min, (7) u-SecA 2 min, (8) c-SecA 5 min, (9) u-SecA 5 min, (10) c-SecA 10 
min, (11) u-SecA 10 min, (12) c-SecA 15 min, (13) u-SecA 15 min. B. Quantification of 
the amount of full-length SecA remaining at each time point and is the average of two 
separate experiments. The intensity of the bands were normalized to undigested SecA 
from lane 1.  
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Figure 2.8 SecA region-specific antibodies 
 
The region-specific antibodies were generated as described by Ramamurthy and Oliver 
(Ramamurthy and Oliver, 1997). The cartoon representation of E. coli SecA is shown on 
the top and is color-coded for the different domains. The residues recognized by the six 
different antibodies (A1-A6) are indicated above the cartoon and the corresponding 
regions in the NMR structure from E. coli (Gelis et al., 2007) (2VDA) are show below. 
Most of the CTL domain was not determined in the NMR structure so this region is 
indicated by the red line in the A6 structure. 
 
  71 
 
  72 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9 Different domain proteolysis in c-SecA and u-SecA 
 
A. The region-specific antibodies against SecA were used to examine the digestion 
pattern of c-SecA. The 15-minute time point is shown with the molecular weight ladder 
indicated on the right side of the gel. The labels are as follows: C–Coomassie blue stained 
gel, A1–antibody against residues 1-209, A2–antibody against residues 211-350, A3–
antibody against residues 351-509, A4–antibody against residues 519-664, A5–antibody 
against residues 665-820, A6–antibody against residues 822-901. Red boxes indicate 
proteolytic fragments that are similar in both c-SecA and u-SecA while the blue boxes 
demonstrate different proteolytic fragments. B. The region-specific antibodies against 
SecA were used to examine the digestion pattern of u-SecA. The 5-minute time point is 
shown with the molecular weight ladder indicated on the right side of the gel. The labels 
are the same as in A. 
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undergoing a conformational change in 2.2 M urea, and that this region of the protein 
could be experiencing similar changes during preprotein recognition at the membrane. 
 
2.2.2.4.Mass Spectrometry of proteolytic fragments 
The predicted chymotrypsin cleavage sites from ExPASy (Gasteiger et al., 2005) 
based on the linear SecA sequence do not completely explain all of the proteolytic 
fragments. To further identify these chymotryptic fragments in u-SecA, we utilized 
matrix assisted laser desorption ionization mass spectrometry (MALDI-MS). Four of the 
u-SecA fragments were analyzed but due to the large size of SecA (901 amino acids) and 
the large number of chymotrypsin cleavage sites, none the u-SecA fragments contained a 
homogenous SecA fragment. Based on the MS peak intensities (see Materials and 
Methods), predicted chymotrypsin cleavage sites, and antibody mapping, we determined 
the most abundant proteolytic species in the u-SecA fragments (Figure 2.10). 
The U50 fragment (Figure 2.10, C) contained peptides covering almost the entire 
SecA sequence. To determine the abundant 50 kD proteolytic fragment(s) in this sample, 
we analyzed the high-intensity peaks (Figure 2.10, C, gray boxes) and discovered two 
SecA chymotryptic fragments were the abundant species. The first fragment contains 
NBF I, PPXD, and half of NBF II, while the second fragment consists of the C-terminal 
portion of the PPXD, NBF II, N-terminal HSD, and the HWD.  These two fragments 
differ only by 1 kD hence they cannot be resolved by SDS-PAGE. The U30 sample was 
analyzed using the same method (Figure 2.10, D). This most abundant fragment is 32 kD 
and is located at the C-terminal end of SecA. Two other minor species of 33 kD and 32 
kD are present in the U30 sample and are in the N-terminal two-thirds of SecA. The  
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Figure 2.10 Mass spectrometry determined protease cleavage sites 
 
A. A four-minute digestion of u-SecA followed by Coomassie blue staining (C) and 
region-specific antibody detection. The boxes indicate the chymotryptic u-SecA fragment 
that was analyzed by MALDI-MS/MS. The molecular weight standard is indicated on the 
left of the gel. B. The notation used to present the MS data in C and D. Manual analysis 
used high-intensity peaks to determine the abundant species in each u-SecA fragment 
analyzed by MALDI-MS/MS (see Materials and Methods). C. MALDI-MS analysis of 
the U50 fragment shows peptide coverage across almost the entire sequence. High-
intensity peak data determined that U50 contained two predominant fragments of 51 kD 
and 52 kD. D. MALDI-MS analysis of the U30 fragment shows peptide coverage across 
almost the entire sequence. High-intensity peak data determined that U30 contained one 
major C-terminal fragment of 32 kD and two other minor N-terminal fragments of 33 kD. 
E. Combining the MS and antibody data, a map of the chymotrypsin cleavage sites in u-
SecA, shown below the cartoon, was determined. The large, medium, and small arrows 
indicate the relative cleavage at each of the sites. The chymotrypsin cleavage sites in c-
SecA, shown above the cartoon, were determined based on the probability of cleavage at 
a specific residue and surface accessibility (see text for details). 
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smaller U27 and U20 fragments were also analyzed but due to numerous MS identified 
peptides, an abundant fragment(s) could not be determined. Using the peptide identified 
by MS experiments and the antibody data, we were able to determine the relative 
cleavage of the chymotrypsin sites in u-SecA (Figure 2.10, E). The surface accessibility 
calculation of the side chain residues of the E. coli NMR structure (2VDA) using 
VADAR software (Willard et al., 2003) identified the surface exposed aromatic residues. 
This data along with the predicted cleavage sites from ExPASy (Gasteiger et al., 2005) 
enabled us to determine the chymotryptic site in c-SecA. Taken together this data 
demonstrates that the C-terminal portion of both c-SecA and u-SecA are proteolytically 
labile. A stable 30 kD fragment is generated if cleavage occurs at Trp622 prior to 
digestion of other parts of HWD, HSD, and CTL. This C-terminal fragment is consistent 
with the 30 kD membrane-inserted domain characterized by Wickner et al. (Price et al., 
1996). 
2.2.2.5.Oligomeric state of u-SecA 
One of the many unresolved questions about SecA’s molecular mechanism during 
the translocation cycle is whether it functions at the membrane as a dimer or a monomer 
(see Chapter 1 section 1.7.1.1. for further discussion). In the case of u-SecA, we also 
needed to determine the oligomeric state of the protein. Typical experiments such as size-
exclusion chromatography yielded ambiguous results so we performed velocity analytical 
ultracentrifugation (AUC) experiments. C-SecA was used as a control since it has 
previously been shown by this method to be a dimer (Woodbury et al., 2002). At 2 µM, 5 
µM, and 10 µM concentrations, c-SecA exists in a dimeric form (Figure 2.11, A) but  
  78 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 AUC of c-SecA and u-SecA 
 
A.  C-SecA at 5 µM was analyzed by velocity analytical ultracentrifugation. The top of 
the graph shows absorbance scans of the cell with the black symbols indicating the scans 
at the beginning of the centrifugation run and red symbols representing the scans at the 
end of the run. The scans were fit to a continuous c(s) distribution model using SEDFIT 
software (Schuck et al., 2002). The sedimentation coefficient translated into a molecular 
weight of 203 kD, which is 1 kD off from the calculated 204 kD molecular weight of 
dimeric SecA. B. The same analysis as in A using 5 µM u-SecA. U-SecA sediments 
much faster than c-SecA and application of the continuous distribution model  indicates 
large molecular weight species. This indicates that u-SecA may be aggregating. 
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u-SecA was found to be in several higher molecular weight species (Figure 2.11, B). 
These larger species are likely due to protein aggregation. To determine if u-SecA was 
aggregating, we used a gluteraldehyde cross-linking approach. Gluteraldehyde is a non-
specific amine-amine cross-linker so residues in close proximity to each other will be 
cross-linked. We used this method to determine the oligomeric state of both c-SecA and 
u-SecA at several different protein concentrations (Figure 2.12). C-SecA is mostly in a 
dimeric state as expected but u-SecA is found in a monomeric form. As the protein 
concentration of u-SecA is increased, some u-SecA is in the dimeric form as well as in an 
aggregated form. This experiment explains the higher molecular species found in the 
AUC experiments with u-SecA.  This result demonstrates that u-SecA is mostly in a 
monomeric form at low protein concentration and that SecA unfolds as a monomer not 
through a dimeric intermediate as previously reported (Doyle et al., 2000) 
2.3. Discussion 
 SecA in the cytosol is in a compact state with low basal level of ATPase activity 
and the atomic details have been described by the available structures (Hunt et al., 2002; 
Sharma et al., 2003; Osborne et al., 2004; Zimmer et al., 2006; Vassylyev et al., 2006; 
Papanikolau et al., 2007). On the other hand, little is actually understood about the highly 
active membrane/translocon bound form of SecA.  Therefore, we generated and 
characterized u-SecA: a full-length, soluble urea intermediate that is in an open and 
active physiologically relevant conformation mimicking the translocation-active form.  
Various studies have demonstrated that when SecA interacts with either the 
phospholipids membrane or the SecYEG translocon, massive structural rearrangements  
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Figure 2.12 Cross-linking demonstrates u-SecA is a monomer 
 
C-SecA and u-SecA oligomeric state was determined by gluteraldehyde cross-linking and 
run on a 6% tricine SDS-PAGE gel. The molecular weight standard is indicated on the 
left side and the different oligomeric forms of SecA are indicated on the right side. The 
lanes are as follows: (1) 0.5 µM cross-linked c-SecA, (2) 1.0 µM cross-linked c-SecA, (3) 
2.5 µM cross-linked c-SecA, (4) 5.0 µM cross-linked c-SecA, (5) 1.0 µM non cross-
linked SecA, (6) 0.5 µM cross-linked u-SecA, (7) 1.0 µM cross-linked u-SecA, (8) 2.5 
µM cross-linked u-SecA (9) 5.0 µM cross-linked u-SecA. C-SecA is predominately in a 
dimeric form while u-SecA is in a monomeric form. The diffuse nature of cross-linked 
band is due to intramolecular cross-linking. 
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occur (Economou and Wickner, 1994; Ding et al., 2001; Natale et al., 2005; Robson et 
al., 2007). This conformational change causes the cytosolic protease-resistant SecA to 
adopt an open, domain-dissociated, and protease-sensitive form. Through limited 
chymotrypsin proteolysis, we determined that NBF I is destabilized in u-SecA (Figure 
2.9, B, A1 lane). The unfolded nature of this domain in u-SecA suggests that it is missing 
an interaction partner. Supporting our observation is a study by Osborne and Rapoport 
(Osborne and Rapoport, 2007), which demonstrated that NBF I of SecA is involved in the 
binding interaction with SecY.  
In our limited protease digestion studies, the PPXD in u-SecA can be subdivided 
into two regions where one region is more protease sensitive than the other (Figure 2.9, 
B, A2 lane). This stabilization of one portion of the PPXD is consistent with the crystal 
structure of SecA /SecYEG complex (Zimmer et al., 2008), which shows that the PPXD 
has rotated far away from the HWD and makes molecular interactions with NBF II. This 
crystal structure also supports our observation that portions of the PPXD, NBF II, and the 
long helix from the HSD form a stable core in the translocation-active form of SecA.  
Previous data has suggested that in the presence of anionic membranes SecA 
partially unfolds and this unfolding event increases membrane insertion (Ulbrandt et al., 
1992). Other evidence showed that about one third of SecA can insert into the membrane 
(Price et al., 1996). Since Trp 701, 723, and 775 contribute most to the overall Trp 
fluorescence (Ding et al., 2001), the C-terminal third of SecA can interact with the inner 
membrane. Our biophysical, proteolysis, and MS data demonstrates that the HWD, C-
terminal HSD, and CTL of u-SecA have dissociated from the rest of the molecule. The 
proteolysis and MS results indicate a stable 30 kD fragment from the C-terminal one-
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third of SecA is generated (Figure 2.9, B, A5 and A6 lanes and Figure 2.10, D). This C-
terminal region is highly protease sensitive in u-SecA but if chymotrypsin cleavage first 
occurs at Trp 623, the released C-terminal region can refold into a more stable fragment. 
This 30 kD fragment is similar to protected membrane-inserted fragment identified by 
Price et al. (Price et al., 1996). The domain dissociation in activated SecA causes the 
release of IRA 1 located in the C-terminal HSD increasing the ATPase activity required 
for preprotein translocation (Karamanou et al., 1999). This conformational change in 
SecA primes the molecule for preprotein translocation and also could reveal a preprotein 
interaction sites that are not accessible in the cytosolic form of SecA.  
In our studies, we determined that u-SecA is in a mostly monomeric form, which 
is consistent with the crystal structure of SecA bound to SecYEG (Zimmer et al., 2008) 
and other translocation experiments (Duong, 2003; Osborne et al., 2004; Osborne and 
Rapoport, 2007). This dissociation of the dimer for translocation likely reveals residues 
needed for specific SecY binding interactions. Additionally, we demonstrated that u-
SecA begins to nonspecifically aggregate at higher protein concentrations. The dimer 
dissociation into the activated translocation state reveals hydrophobic surfaces for 
binding interactions with SecY, preprotein, and the inner membrane. In u-SecA these 
interaction region are unsatisfied leading to aggregation. These observations suggest that 
the monomeric form of SecA is important in the translocation cycle. 
Using our results in conjunction with previous studies, we propose a model of 
SecA interactions with the inner membrane and the SecYEG translocon. Upon interaction 
with the translocon, the SecA dimer dissociates into a monomer and undergoes massive 
structural rearrangements. This conformational change breaks PPXD interactions with the 
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HWD and promotes NBF I binding to the translocon (Figure 2.13). The loss of the PPXD 
interactions drive the HWD, C-terminal HSD, and CTL insertion into the membrane, 
which in Gram-negative bacteria induces SecB dissociation. These new interactions 
create the proper positioning of SecA for the productive translocation of preproteins. 
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Figure 2.13 Model of the conformation change in SecA upon binding SecYEG 
 
The different domains of SecA have been color-coded: blue, NBF I; yellow, PPXD; 
purple, NBF II; green, N-terminal HSD; orange, HWD; dark green, C-terminal HSD; and 
red, CTL. (1) Cytosolic SecA is in a closed antiparallel dimeric form and has low ATPase 
activity. (2) Upon interaction with SecY the SecA dimer dissociates. (3) The HWD, C-
terminal HSD, and CTL dissociate from the rest of the SecA monomer and insert into the 
membrane. This new conformation positions SecA on the SecYEG translocon for 
productive translocation of preproteins. 
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2.4. Materials and Methods 
2.4.1. Recombinant DNA experiments 
2.4.1.1.Cloning of SecA gene 
 
The SecA gene was amplified by PCR from the pT7-SecA2 plasmid (D. Oliver, 
Wesleyan University) using forward primer (5′-GGAATTCCATATGCCTAATCAA 
ATTGTTAAC-3′; introduced restriction enzyme sites are underlined) and reverse primer 
(5′-CCGCTCGAGTTATTGCAGGCGGCCATGGC-3′) using Taq DNA Polymerase 
(New England Biolabs, Ipswich, MA). The 2.7-kb PCR fragment was subcloned into the 
pGEM®-T vector (Promega, Madison, WI). The resulting plasmid was digested with 
NdeI/XhoI restriction enzymes (New England Biolabs, Ipswich, MA) and ligated into the 
same sites in pET17b (Novagen, Madison, WI) creating the pET-17b-FL SecA plasmid. 
DNA sequencing (Davis Sequencing, Davis, CA) verified the correct sequence of the 
SecA gene.  
2.4.1.2.Site-directed mutagenesis 
Sequencing results from the pET-17b-FL SecA revealed the presence of two point 
mutations. One mutation was silent while the other one changed an amino acid T371A. 
The mutagenesis primer (5’-CCAGAACGAAAACCAAACGCTGGCTTCGATCACC-
3’) and its complement (the single nucleotide change underlined) were used to change the 
Ala back to Thr at position 371. Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA) 
was used with 50 ng of pET-17b-FL SecA 371A and 125 ng of each primer to 
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incorporate the single nucleotide change following the manufacture’s protocol. DNA 
sequencing (Davis Sequencing, Davis, CA) verified the incorporation of the mutation in 
the SecA gene. 
2.4.2. Protein expression and purification 
The pET-17b-FL SecA plasmid was transformed into the BL21 (DE3) bacterial 
strain. Cells were grown at 37°C to OD600 of 0.5 in LB supplemented with LinA salts and 
50 µg/ml ampicillin. Expression of SecA protein was induced by the addition of IPTG to 
a final concentration of 0.75 mM and the culture was grown for another 2.5 hours at 
37°C. The bacterial cells were pelleted, resuspended in lysis buffer (50 mM Tris pH 7.6, 
100 mM NaCl, 1 mM DTT), frozen in liquid nitrogen, and stored at -80°C until 
purification. 
SecA protein was purified as described previously (Fak et al., 2004) with some 
modifications. Bacterial cells were treated with a cocktail of protease inhibitors (150 µM 
PMSF, 250 µg leupeptin, 10 µg pepstatin, 150 µM ABESF) followed by lysis. Cell lysis 
was performed either by lysozyme treatment and sonication or by microfluidics system. 
For lyssozyme treatment, cells were thawed and 20 mg of lysozyme was added (per liter 
of original culture). The cells were incubated on ice for 20 minutes and then 4 mg of 
DNase I was added (per liter of original culture) and incubated on ice for 10 minutes. The 
cells were sonicated for 30 seconds followed by two minutes on ice for a total of five 
cycles. For lysis by the microfluidics system, the cells were thawed and the total volume 
was increase to 30 ml with lysis buffer. The cells were passed through the micro 
fluidizer® processor (Microfluidics, Newton, MA) at a pressure of 16,000 PSI two times. 
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After a 10,000 rpm spin at 4°C, the supernatant was passed through a 0.22 µm filter and 
loaded onto a DEAE Sepharose CL-6B (Sigma, St. Louis, MO) column equilibrated with 
50 mM Tris pH 7.6, 1 mM DTT, 0.025% NaN3. The protein was purified on an AKTA 
purification system (GE Healthcare, Piscataway, NJ) using a 100 ml salt gradient from 0 
to 1 M NaCl. Fractions were run on 8% Tricine SDS-PAGE. Relevant fractions 
containing the SecA protein were pooled and loaded onto a SP Sepharose Fast Flow 
(Sigma, St. Louis, MO) column equilibrated with 50 mM HEPES pH 7.5, 1 mM DTT, 
0.025% NaN3. The loaded protein was purified using a 100 ml salt gradient from 0 to 1 
M NaCl. Fractions were run on 8% SDS-PAGE to determine which fractions contained 
SecA protein and the relevant fractions were concentrated to a final volume of 2.5 - 5 ml. 
The concentrated SecA protein was injected onto a Superdex 200 prep grade (GE 
Healthcare, Piscataway, NJ) gel filtration column equilibrated with 25 mM Tris pH 7.6, 
150 mM KCl, 1 mM MgCl2. The relevant fractions containing pure SecA were pooled, 
concentrated, snap-frozen in liquid nitrogen, and stored at -80°C. Protein concentration 
was determined by absorbance at 275 nm (the peak absorbance for SecA in an 
absorbance scan) after dilution into 6 M guanidinium-HCl, 20 mM sodium phosphate pH 
6.5, assuming an extinction coefficient of 0.73 OD per mg mL-1. Each batch of protein 
was checked for ATPase activity by the enzyme-coupled ATPase assay and secondary 
structure by far-UV CD. 
2.4.3. Enzyme-coupled ATPase assay 
The ATPase activity of purified SecA was measured by the steady-state enzyme-
coupled ATPase assay. This assay uses pyruvate kinase and lactate dehydrogenase to 
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couple the ATP hydrolysis to the conversion of NADH to NAD+ (Norby, 1988). To pre-
equilibrate the sample, 400 nM SecA was added to 50 mM Tris pH 8.0, 30 mM KCl, 30 
mM NH4Cl, 1 mM DTT, 5 mM Mg(OAc)2, 3 mM phospho(enol)pyruvate, 10 U of 
pyruvate kinase, and 14.4 U of lactate dehydrogenase at 37°C for 15 minutes. After pre-
equilibration, 0.5 mM ATP and 0.25 mM NADH was added to the reaction mixture and 
the change in transmittance at 340 nm was monitored using the J715 spectropolarimeter 
(JASCO) instrument at 37°C for 16 minutes. The rate of hydrolysis was determined by 
changing the percent transmittance to absorbance. The absorbance at 340 nm over time 
was plotted excluding the first 60 seconds in which the reaction was achieving steady-
state and the slope was determined by linear least squares curve fitting. The change in 
absorbance is directly proportional to the mole of NADH hydrolyzed using the ε340 of 
NADH as 6.22 x103 cm-1 M-1. The correspondence between NADH hydrolyzed and ATP 
hydrolysis is 1:1, therefore, the rate of ATP hydrolysis is equal to the rate measured for 
NADH depletion. The ATPase activity was expressed as pmol ATP hydrolyzed/µg SecA 
minute and was the average of three independent measurements. 
2.4.4. Far-UV CD 
CD spectra of proteins were measure using a J715 spectropolarimeter  (JASCO). 
Spectra were taken in the far-UV region from 195-250 nm using a 1-mm pathlength cell. 
Scan speed was 20 nm/min and five scans were averaged. The samples were in 300 µl of 
10 mM KHPO4 pH 7.6 and 1 mM MgCl2 at a concentration of 0.5 or 1 µM. The spectra 
were buffer corrected. 
  92 
2.4.5. ATPase assay in urea 
The ATPase activity of SecA in various urea concentrations was measured using 
the malachite green-ammonium molybdate ATPase assay (Lanzetta et al., 1979) with o-
phosphoric acid (Sigma, St. Louis, MO) as a standard curve.  After equilibration at 22°C 
for 12 – 14 hours of 1 µM SecA in 50 mM Tris pH 8.0, 30 mM KCl, 30 mM NH4Cl, 5 
mM Mg(OAc)2, 1 mM DTT with various concentrations of urea, 5 mM ATP was added 
and the reaction was incubated for one hour at 22°C. The absorbance was measured at 
660 nm using a Genesys 10 UV scanning  spectrophotometer (Thermo Electron Corp). 
2.4.6. Equilibrium fluorescence measurements 
Samples containing 1 µM SecA were incubated at 22°C with various 
concentrations of urea in 50 mM Tris pH 8.0, 30 mM KCl, 30 mM NH4Cl, 5 mM 
Mg(OAc)2, 1 mM DTT for 12-14 hours.  Trp fluorescence of SecA was measured using a 
Photon Technology International QM-1 spectrofluorometer at 22°C. The fluorescence 
excitation wavelength was 295 nm and the emission spectra were measured from 300 to 
380 nm. The excitation and emission bandwidths were both set to 2 nm. The fluorescence 
signal at 340 nm was plotted against the urea concentration and corrected for background 
fluorescence using urea buffer. 
2.4.7. CD measurements in urea 
Far-UV CD measurements of 1 µM SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 
1 mM MgCl2, 1 mM DTT with various concentrations of urea incubated at 22°C 
overnight were recorded on a J715 spectropolarimeter  (JASCO) from 215-250 nm using 
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a 1-mm pathlength cell.  Scan speed was 20 nm/min and five scans of each sample were 
averaged. Spectra were taken of urea buffer to substrate any background signal. 
2.4.8. Limited proteolysis 
C-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT and u-
SecA at 2.5 µM in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT, 2.2 M 
urea were generated by incubation at 22ºC for four hours. The samples were subjected to 
a time course of limited α-chymotrpysin (1:150 w/w) digestion from 0 to 60 minutes. At 
each time point, adding 3X SDS-PAGE sample buffer and flash freezing in liquid 
nitrogen quenched the digestion. Samples were either boiled and subjected to SDS-PAGE 
or stored at -80°C until further use. The samples were run in duplicate on two 8% or 10% 
SDS-PAGE gels. The gels were either stained with Coomassie blue or transferred to 
PVDF membrane for further analysis. 
2.4.9. Antibody Detection 
Digested c-SecA and u-SecA protein transferred to PVDF membrane was 
detected with region-specific SecA antiserum (Ramamurthy and Oliver, 1997) to 
determine the identity of the proteolytic bands.  The blots were blocked overnight at 4°C 
or at room temperature for one hour in 5% non-fat milk in Tris-Buffered Saline with 
0.5% Tween 20 (TBS-T). After washing with TBS-T, the blot was probed with one of the 
region-specific antibodies at 1:5000 dilution in TBS-T for one hour at room temperature.  
Next, a secondary goat anti-rabbit IgG alkaline phosphatase (AP) conjugated antibody 
(Sigma) was used according to the manufacturer’s protocol. Antibodies were detected by 
AP Lumino (Pierce, Rockford, IL) using a G:Box gel documentation unit (Syngene, 
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Frederick, MD).  Blots were stripped in 50 mM Tris pH 6.8, 2% SDS, and 100 mM β-
mercaptoethanol buffer at 55°C for one hour. The blots were then reprobed with the 
secondary antibody, and if no background signal was detected, the blot was blocked and 
probed with the other region-specific antibodies following the above protocol. 
2.4.10. Mass spectrometry 
Four u-SecA fragments, U50, U30, U27, and U20 numbered for their apparent 
molecular weight, were analyzed by MALDI-MS/MS. The fragments were excised from 
8% tricine SDS-PAGE gel using a clean razor and analyzed by the Center for Advanced 
Proteomics Research at the New Jersey Medical School of the University of Medicine 
and Dentistry of New Jersey. The gel pieces were washed with 30% acetonitrile in 50 
mM ammonium bicarbonate followed by reduction with DTT and alkylation with 
iodacetamide. The samples were further digested with trypsin at 37°C overnight. The 
resulting trypsin digested peptides were extracted with 1% trifluoracetic acid two time 
followed by 80% acetonitrile. The samples were concentrated using a speed vac and 
desalted using C18 ZipTips. The SecA peptides were mixed in a 1:1 ration with 7 mg/ml 
α-cyano-4-hydroxy-cinnamic acid and spotted onto the MALDI plate. The data was 
analyzed using the local Mascot search against the E. coli SecA sequence. The variable 
modifications employed were oxidized methionine and carbamidomethyl labeled-
cystenine and the error of the MS was within 50 ppm.  
Due to the heterogeneous nature of the original α-chymotrypsin fragments further 
manual analysis was performed. Taking into consideration all of the peptides that were 
detected by the MS analysis, the size of the original chymotrypsin U50 fragment would 
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correspond to an 83 kD fragment. In the mass spectrum, a single peak of high intensity 
does not correlate to the most abundant peptide but if most of the intense peaks cluster to 
one region of the protein, that region is likely the most abundant species in the original u-
SecA chymotryptic fragment. A threshold of 10% intensity was set to determine all of the 
high intensity peaks. All of the high-intensity peaks corresponding to the four original 
fragments were mapped onto the SecA sequence. Based on the predicted chymotrypsin 
cleavage sites along with the intensity analysis, the abundant species in the original U50 
and U30 SecA fragments were identified. For the smaller U27 and U20 fragments, the 
clustering of the MS intensities no longer applies due to the large number of proteolytic 
fragments of similar sizes. The sequencing data from the MS/MS was used to determine 
if a particular chymotrypsin cleavage site was used. If any of the aromatic residues 
appeared in the sequenced peptide of all four u-SecA fragments more than two times, this 
residue was not  considered to be cleaved in the original chymotryptic digestion. From 
this analysis the cleavage sites in u-SecA were assigned.  
2.4.11. Velocity analytical ultracentrifugation 
C-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP and 
u-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP, 2.2 M urea, 
at 2 µM, 5 µM, and 10 µM were equilibrated overnight at 22°C. SecA samples and buffer 
were loaded into cells containing two-sector centerpieces. The An-60 Ti rotor was 
equilibrated to 22ºC prior to the AUC run. The three separate cells containing samples 
were centrifuged at 30,000 rpm until sedimentation of the protein was complete. Radial 
scans measured the absorbance profile of each of the three samples at four-minute 
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intervals. The sedimentation coefficient was determined using the SEDFIT software 
(Schuck et al., 2002) using the continuous c(s) distribution model. The partial –specific 
volume, density, and viscosity of both samples were calculated using the freeware 
program SEDNTERP (http://www.jphilo.mailway.com/). The partial-specific volume 
used for both samples is 0.7335. The density and viscosity values used are 1.00071 and 
0.01002 for c-SecA and 1.03508 and 0.010997 for u-SecA.  
2.4.12. Gluteraldehyde Cross-linking 
C-SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT and u-
SecA in 20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT, 2.2 M urea were 
equilibrated for four hours at 22°C. Gluteraldehyde was added to a final concentration of 
0.1% and incubated at room temperature for two minutes. The cross-linking was 
quenched by the addition of 100 mM Tris pH 8.0. The samples were boiled for five 
minutes and loaded onto a 6% Tricine SDS-PAGE. The proteins were visualized by 
staining the gel with Coomassie Blue.  
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CHAPTER 3 
SIGNAL SEQUENCE INTERACTIONS WITH CYTOSOLIC SECA AND 
TRANSLOCATION-ACTIVE SECA 
3.1. Introduction 
A critical step in the post-translational secretion pathway in bacteria is the 
recognition and binding of the signal sequence by SecA. After the preprotein has been 
translated by the ribosome, either SecB interacts with the mature region of the preprotein 
to maintain it in an unfolded state or the preprotein is recognized by cytosolic SecA. The 
preprotein/SecB complex is targeted to SecA, which binds the signal sequence and 
mature region of the preprotein and SecB. Upon interactions with the preprotein/SecB 
complex as well as with the SecYEG translocon, SecA undergoes a dramatic 
conformational change into the translocation-active form (Figure 3.1). This structural 
rearrangement likely reveals a higher affinity signal sequence-binding site that is used as 
a proofreading step prior to insertion of the precursor into the SecYEG translocon. SecA 
correctly positions the preprotein and uses ATP hydrolysis for translocation through the 
SecYEG channel (Clerico, 2008). Despite the vast amount of biochemical and 
biophysical experiments performed to try to identify the signal sequence-binding site, its 
exact location in both cytosolic and translocation-active SecA is still poorly defined.  
Various biochemical methods have been used to try to determine the region where 
signal sequences bind SecA. Kimura et al. (Kimura et al., 1991) first tried to try to 
identify the signal sequence-binding site using the zero-length cross-linker, 1-ethyl-3-(3-
dimethylaminoproyl) carbodiimide (EDC), which couples carboxyl groups to primary 
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Figure 3.1 Model for SecA-mediated translocation 
 
The preprotein (pink) is translated by the ribosome nascent chain complex (RNC). 
Tetrameric SecB (tan hexagons) binds the preprotein keeping it in an unfolded state. 
SecA (green) interacts with the SecB/preprotein complex and binds to the SecYEG 
translocon and undergoes a major conformational change. SecA binds the signal 
sequence (red box) of the preprotein and positions the preprotein for translocation 
through SecYEG. 
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amines. Reconstituted SecA fragments were cross-linked to radio-labeled in vitro 
translated preproteins. These experiments indicated that the preprotein cross-linked to the 
N-terminal portion of SecA and demonstrated that residues 267-340 encompassed the 
binding site.  
Initial studies performed by our group, compared the binding of signal peptides to 
full-length SecA and an activated form of SecA, SecA64, which is a 64 kD N-terminal 
chymotryptic fragment generated in the presence of ATP. This experiment showed that 
signal peptides bound more strongly to SecA64 than to full-length SecA (Triplett et al., 
2001). These results suggest that either the signal sequence-binding site is more 
accessible in SecA64 or that the activated form of SecA has a different binding site. 
Efforts to identify the signal sequence-binding site began in earnest when the first 
crystal structure of SecA was solved by Hunt el al. (Hunt et al., 2002), a computer 
program VOIDOO (Kleywegt and Jones, 1994) was used (Hunt et al., 2002) to detect 
unknown grooves or cavities on the surface of the structure.  Three regions were 
identified as possible preprotein interactions sites: the CTL groove, the single-stranded 
nucleic acids (SS-NA) groove, and the methionine canyon (Figure 3.2, A). Each of these 
cavities is located at an interface between two or more domains. Binding of the signal 
sequence of a preprotein to the CTL groove would require the displacement of the CTL 
of SecA (Hunt et al., 2002). Previous studies have shown that SecB binds to the CTL of 
SecA, and this likely disengages the CTL from the rest of the molecule (Dempsey et al., 
2004). Our group previously reported (Chou and Gierasch, 2005) the structure of the 
signal peptide bound to SecA and proposed a binding site in the same region as the CTL 
groove (Figure 3.2, B, red and green), which has both electrostatic and hydrophobic  
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Figure 3.2 Proposed signal sequence binding regions 
 
A. Surface and cartoon representation of the B.subtilis SecA crystal structure (Hunt et al., 
2002) (1M6N) color-coded for the different domain: blue, first nucleotide binding fold 
(NBFI); yellow, preprotein cross-linking domain (PPXD); purple, second nucleotide 
binding fold (NBFII); green, α-helical scaffold domain (HSD); orange, α-helical wing 
domain (HWD); and red, carboxyl-terminal linker (CTL). The black boxes indicate the 
location of possible ligand-binding sites, CTL groove, single-stranded nucleic acids (SS-
NA) groove, and methionine canyon. B. Monomeric B.subtilis SecA crystal structure 
(Osborne et al., 2004) (1TF5) surface and cartoon representation color-coded for 
proposed signal sequence binding regions: red, Chou and Gierasch, 2005 (Chou and 
Gierasch, 2005); blue, Papanikou et al., 2005 (Papanikou et al., 2005); green, overlap 
between the latter two sites; cyan, Musial-Siwek et al., 2007 (Musial-Siwek et al., 2007); 
yellow, Osborne et al., 2004 (Osborne et al., 2004). C. Cartoon and surface representation 
of the E. coli SecA NMR structure (Gelis et al., 2007) (2VDA) color-coded for domains 
as described above. The modeled signal peptide is shown in cyan. D. Structure of SecA 
from T. maritima represented by surface and cartoon bound to SecYEG (not shown) 
(Zimmer et al., 2008) (3DIN). The arrow represents the clamp region proposed to be a 
potential signal sequence binding site. 
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character. SecA has structural homology to helicases, and the proposed SS-NA groove is 
analogous to the site where nucleic acids interact with helicases. The methionine canyon 
at the interface between NBF II and the N-terminal HSD has weakly packed Met residues 
(Hunt et al., 2002). In SRP the signal sequence has been shown to interact with the Met-
rich M-domain (Zopf et al., 1993), which has a hydrophobic groove lined with Met 
residues (Bernstein et al., 1989). All of these potential interaction sites are located within 
the first two-thirds of the SecA molecule, which is consistent with the finding that signal 
peptides interact with SecA64 (Triplett et al., 2001). 
In another study, Economou and co-workers (Baud et al., 2002) used chemical 
cross-linking with dithiobis(succinimidyl propionate) to demonstrate that a synthetic 
alkaline phosphatase signal peptide interacts with N-terminal fragments of SecA 
containing the first 263 residues. They further showed by deletion analysis that residues 
219-244 are essential for signal peptide binding but residues 234-263 may be needed for 
optimal signal sequence-binding (Baud et al., 2002). This proposed binding region is 
located in the preprotein cross-linking domain (PPXD), which was so named from the 
results presented in the original preprotein cross-linking study by Kimura et al. (Kimura 
et al., 1991). These results were further supported by surface plasmon resonance assays, 
which showed that several SecA modification including C-terminal truncation (residues 
1-610), IRA1 deletion (Δ783-795) (for further discussion of IRA1, see Chapter 1), or 
mutation of Trp775 to Ala, increase binding to the immobilized signal peptide when 
compared to wild-type SecA (Vrontou and Economou, 2004). These results indicate that 
IRA1 may be acting as a molecular switch to regulate signal sequence binding (Baud et 
al., 2002). This group also studied the PPXD in isolation as well as various SecA deletion 
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mutants to determine if the PPXD could bind both the signal peptide and the mature 
region of the preprotein. They found that signal peptides can bind directly to the isolated 
PPXD and stabilize this domain in a distinct conformation (Papanikou et al., 2005).  
The PPXD can be further broken down into two subdomains, the stem (residues 
219-240 and 362-377) and the bulb (residues 234-361). Through protease protection 
assays using either a signal sequence or a mature region of a preprotein, signal sequences 
were shown to bind to the stem region (Figure 3.2, B, blue and green) while the mature 
region of the preprotein can bind to the bulb (Papanikou et al., 2005). This potential 
signal sequence binding to the stem region consistent with to the CTL groove proposed in 
by (Hunt et al., 2002) when the first crystal structure of SecA was solved. 
In 2004 Rapoport and co-workers (Osborne et al., 2004) solved the crystal 
structure of a monomeric version of SecA. In this structure, the PPXD has rotated and 
moved away from the HWD creating a groove between these two domains. Based on this 
structure, this group proposed two alternative preprotein binding grooves. Groove 1 is 
located between the PPXD and HWD and is lined with several polar and charged residues 
(Figure 3.2, B, yellow). The second proposed site, groove 2, overlaps with the signal 
sequence-binding site proposed by several other groups (Figure 3.2, B, blue, green, and 
red) (Papanikou et al., 2005; Chou and Gierasch, 2005; Hunt et al., 2002).  
In order to determine the region important for signal sequence-binding, Musial-
Siwek et al. (Musial-Siwek et al., 2005) monitored signal peptide binding to SecA by 
fluorescence resonance energy transfer (FRET). In this case, the intrinsic Trp residues of 
SecA were used as the donor, and the alkaline phosphatase signal sequence synthesized 
with a C-terminal Cys, which was labeled with IAEDANS, served as the acceptor. Using 
  105 
this system they were able calculated that c-SecA has one signal sequence-binding site 
with a Kd of 2.4 µM but in lipid vesicles the binding fit best to a two-state model with a 
Kd1 of 0.9 µM and Kd2 of 11.2 µM. By Trp mutagenesis, they observed that Trp 349 
appears to contribute the most to the FRET signal but Trp 775 also appears to play a role. 
They also observed that mutations to residues in the third helix of the PPXD also 
decreased FRET efficiency, indicating that this region may be important for signal 
sequence-binding. Subsequently, this same group performed cross-linking studies using a 
synthetic alkaline phosphatase signal peptide. At the end of the h-region of the signal 
peptide, benzoylphenylalanine was incorporated as a photoactivatable cross-linker and 
the C-terminal Cys labeled with biotin. At various regions throughout the SecA protein 
they incorporated Factor Xa cleavage sites to specifically cleave SecA into two parts. 
Through cross-linking of the signal peptide to the various SecA mutants, digesting with  
Factor Xa, and detecting of the biotin, they observed cross-linking to residues 269-322 
(Figure 3.2, B, cyan), (Musial-Siwek et al., 2007) which is similar to the site identified by 
Kimura (Kimura et al., 1991). 
Recently, an NMR structure of the SecA homodimer was determined using a 
domain-parsing strategy in conjunction with specific labeling of the methyl groups of Ile, 
Leu, Val, and Met (Gelis et al., 2007). To determine the structure of the complex between 
c-SecA and the signal sequence, Cys mutants of the KRRLamB signal peptide were 
labeled with a nitroxide spin label. Using methyl-TROSY experiments, the distance-
dependent broadening of the NMR signals by the nitroxide-labeled signal peptide were 
obtained. Changes in the methyl resonance intensities of SecA in the presence of the 
signal peptide were converted to distances. From these distance constraints, models of 
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signal peptide bound to SecA were generated. The orientation of the signal peptide bound 
to SecA was determined by labeling the signal peptide with nitroxide at two different 
positions, before and after the hydrophobic core. The proposed binding site on SecA is 
the groove between the PPXD and HWD with the signal peptide interacting 
predominantly with the PPXD (Figure 3.2, C). The groove has both hydrophobic and 
electrostatic components (Gelis et al., 2007). This site is not accessible in the original 
crystal structure because the PPXD packs against the HWD (Hunt et al., 2002) (Figure 
3.2, A). In the monomeric version of B. subtilis SecA (Osborne et al., 2004) and as well 
as the NMR structure (Gelis et al., 2007), the PPXD has rotated slightly and moved so 
there are no interactions with the HWD (Figure 3.2, C). This binding region modeled 
from the NMR distance restraints (Gelis et al., 2007) and the site determined by the 
FRET and cross-linking studies (Musial-Siwek et al., 2005; Musial-Siwek et al., 2007) 
are in similar regions on the PPXD. This region also has some overlap with the stem 
region (residues 219-240 and 362-377) (Papanikou et al., 2005) as well as groove 1 from 
the monomeric crystal structure (Osborne et al., 2004) (Figure 3.2). 
All of the signal sequence-binding studies except for Musial-Siwek et al. (Musial-
Siwek et al., 2007) have been performed on the cytoplasmic form of SecA, which is not 
the conformation involved in the translocation reaction (see the introduction to Chapter 2 
for a detailed description). A new low resolution structure of truncated SecA bound to the 
SecYEG translocon has recently been solved (Zimmer et al., 2008) and may provide a 
framework for signal sequence binding to SecA. From this structure, a new preprotein 
binding site was proposed. In this SecA structure, the PPXD has rotated even further 
away from the HWD and makes contact with both SecY and NBF I. The PPXD, NBF II, 
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and portions of the HSD form a new ‘clamp’ region, which is lined with conserved 
residues some of which forms a hydrophobic patch (Figure 3.2, D).  This region could be 
used to recognize the signal sequence and position the preprotein above the SecY pore 
(Zimmer et al., 2008). A previous study (Cooper et al., 2008) using site-directed spin 
labeling with electron paramagnetic resonance (EPR) spectroscopy with SecA, 
preproteins, and inverted membrane vesicles supports the preprotein interactions with the 
‘clamp’ region.  
Although a significant amount of work has been performed to identify the signal 
sequence-binding site on SecA, the location of the site is still unclear especially in the 
translocation-active form. Nearly all of the studies have been performed on the cytosolic 
form of SecA, which is likely not to be the physiologically relevant form of the protein 
needed for signal sequence binding. Identifying the signal sequence-binding site on the 
membrane- or translocon-bound form of SecA has been difficult due to the presence of 
liposomes and other components of the secretory pathway. This chapter describes signal 
sequence interactions with c-SecA and u-SecA, a soluble translocation-active form of 
SecA, as well as cross-linking studies to define the signal sequence-binding region on 
both forms. A possible signal sequence recognition mechanism is proposed based on the 
results and the recently published SecA/SecYEG crystal structure (Zimmer et al., 2008). 
3.2. Experimental strategy 
In Chapter 2, we established that low concentrations of urea convert SecA to a 
state (u-SecA) that mimics the translocation-active form of full-length SecA. U-SecA 
thus provides a system to determine the signal sequence-binding site on the translocation-
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active form of SecA. To gain further insights into the translocation mechanism, the signal 
sequence-binding site on both the cytosolic and translocation-active forms of SecA must 
be determined. We have developed a powerful strategy using photoactivatable cross-
linking in conjunction with limited proteolysis, two-dimensional gels, biotin and region-
specific SecA antibody detection to map the signal peptide binding region on both c-
SecA and u-SecA. 
In our strategy, the N-terminal biotinylated modified LamB signal peptide, Bio-
KRRLamB19C, was labeled with the photoactivatable cross-linker 4-maleimido-
benzophenone. The biotin on the signal peptide allows for the specific detection of only 
the cross-linked products. As shown in Chapter 2, c-SecA is relatively resistant to 
protease digestion. In order to compare the cross-linking patterns between c-SecA and u-
SecA, c-SecA was first cross-linked to signal peptide (Figure 3.3 (A1)) followed by 
incubation in urea in the same conditions that were used to generate u-SecA (A2) before 
proteolysis. This enables the cross-linking to occur in the c-SecA form but leads to the 
same conditions for limited chymotrypsin digestion (A5). U-SecA was generated as 
described in Chapter 2 (A3), cross-linked to signal peptide (A4), and subjected to limited 
protease digestion (A5). 
Due to the large size of the SecA protein, numerous chymotryptic cleavage sites 
are anticipated. SecA has 40 potential digestion sites predicted from ExPASy (Gasteiger 
et al., 2005) with a probability threshold set at 80% based on enzyme specificity for the 
surrounding sequence. Chymotrypsin preferentially digests at aromatic residues, and the 
probability of cleavage is based upon the type of amino acid in the sequence before and 
after the preferred aromatic residue (Keil, 1992). Therefore, chymotrypsin digestion may  
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Figure 3.3 Experimental design and data analysis 
 
Flow charts of the experiment design for the 2-D gels and for how the data from the 2-D 
gels was processed.  
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generate several different proteolytic SecA fragments of similar molecular weight. This 
complexity of the SecA digestion pattern makes antibody mapping by one-dimensional 
SDS-PAGE difficult to resolve.  
To circumvent this problem, cross-linked SecA fragments were analyzed by two-
dimensional gel electrophoresis. The first dimension is isoelectric focusing (IEF), which 
separates fragments based on their isoelectric point (Figure 3.3 (A6)), and the second 
dimension is molecular weight separation by SDS-PAGE (A7). This powerful technique 
with antibody mapping enabled the identification of different SecA domains involved in 
binding of signal sequences (A9, A10). The analysis of the two-dimensional gels for 
cross-linked proteins by biotin detection and antibody mapping is not trivial. Manual 
analysis of the biotin detection (Figure 3.3, (B1)) of the two-dimensional gels was 
performed to compare the pattern of cross-linked fragments between c-SecA and u-SecA 
(B2) and differences in the cross-linking pattern were identified (B3). The identities of 
the cross-linked  SecA fragments were manually assigned using the SecA region-specific 
antibody data (B4) and the identifications of the cross-linked fragments from c-SecA and 
u-SecA were compared (B5). Using the mass spectrometry results of the chymotrypsin 
SecA fragments from Chapter 2, we were able to identify the cross-linked SecA 
proteolytic fragments (Figure 3.4, A). This powerful approach has enabled us to 
determine the signal sequence-binding region on both the soluble and translocation-active 
forms of SecA. 
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Figure 3.4 Map of chymotrypsin cleavage sites 
 
Based on the surface accessibility of the aromatic residues and mass spectrometry results 
from Chapter 2, the chymotrypsin cleavage sites are shown. The linear sequence of SecA 
is color-coded for the different domains and the region-specific antibodies are indicated 
above the cartoon. The relative cleavage at each site is indicated by the thickness of the 
arrow. B. The cartoons illustrate the different proteolytic fragments of SecA cross-linked 
to signal peptide in the 2-D gels. The SecA cross-linked fragments are broken down into 
three subsets based on domains. The name of each fragment is indicated on top of the 
cartoon. 
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3.3. Results 
3.3.1. Establishing the validity of the SecA-signal peptide interaction 
Although signal peptide binding to c-SecA has previously been established (Gelis 
et al., 2007), we needed to confirm that signal peptides bind to u-SecA in a specific 
manner. Due to the complications of working with the highly hydrophobic signal peptide 
and working in urea solutions, typical binding assays were unsuccessful so we developed 
a qualitative gluteraldehyde cross-linking based binding assay. This method uses 
gluteraldehyde to cross-link a biotinylated KRRLamB19C signal peptide (Figure 1.2, B) 
to c-SecA and u-SecA. Therefore, if the signal peptide is bound to either conformation of 
SecA, the protein and signal peptide will be cross-linked upon addition of glutaraldehyde.  
The cross-linked samples were run on tricine SDS-PAGE gels and transferred to a 
PVDF membrane. The biotin signal from the signal peptide was detected by streptavidin-
horseradish peroxidase (HRP). Only cross-linked SecA protein, which migrated around 
100 kD for the monomer or about 200 kD for the dimer are detected by streptavidin-HRP. 
In this set of experiments, the amount of Bio-KRRLamB19C signal peptide was held 
constant while the concentration of c-SecA or u-SecA was increased. For both forms of 
SecA, the biotin signal increased as the concentration of protein was increased (Figure 
3.5). As shown in Chapter 2, c-SecA is predominantly in a dimeric form but in this signal 
peptide binding assay the small amount of monomeric c-SecA also binds signal peptide 
(Figure 3.5, A, B). This is likely to be a non-specific binding event since the signal of the 
monomer does not increase as the protein concentration is increased.  
  115 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Signal peptide binding assay 
 
Gluteraldehyde cross-linking was used to assess if either form of SecA can bind a 
biotinylated signal peptide. A. Biotin detection (top) and Coomassie blue stained SDS-
PAGE gel (bottom) of increasing concentrations of c-SecA cross-linked to 1.0 µM Bio-
KRRLamB19C signal peptide. The c-SecA concentrations in the lanes are as follows: (1) 
0.13 µM, (2) 0.21 µM, (3) 0.44 µM, (4) 0.49 µM, (5) 0.61 µM, (6) 0.87 µM, (7) 1.0 µM, 
(8) 1.41 µM, (9) 1.81 µM. Dimeric SecA migrates at 204 kD while monomeric SecA 
migrates at 102 kD. B. Quantitation of the biotin signal from two different experiments. 
Due to variation in the protein concentrations only six concentrations are shown. Dimeric 
SecA is shown by the red bars while monomeric SecA is shown by the blue bars. C. 
Biotin detection (top) and Coomassie blue stained SDS-PAGE gel (bottom) of increasing 
concentrations of u-SecA cross-linked to Bio-KRRLamB19C signal peptide. The u-SecA 
concentrations in the lanes are as follows: (1) 0.01 µM, (2) 0.14 µM, (3) 0.41 µM, (4) 
0.68 µM, (5) 1.0 µM, (6) 1.25 µM, (7) 1.29 µM, (8) 1.47 µM, (9) 1.63 µM. Dimeric 
SecA migrates at 204 kD while monomeric SecA migrates at 102 kD. D. Quantitation of 
the biotin signal from two different experiments. Due to variation in the protein 
concentrations only six concentrations are shown. . Dimeric SecA is shown by the red 
bars while monomeric SecA is shown by the blue bars. 
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In u-SecA most of the signal peptide binds to the monomer but as the total protein 
concentration increases more dimer is present (Figure 3.5, C, D). The titrations cannot be 
performed at higher protein concentrations because c-SecA forms higher oligomers (Shin 
et al., 2006) and u-SecA begins to aggregate non-specifically. In both cases, the 
functional form, dimer for c-SecA and monomer for u-SecA, appears to saturate around a 
protein concentration of one µM. This qualitative value is comparable to binding 
affinities previously reported. (Musial-Siwek et al., 2005; Gelis et al., 2007). We 
concluded that signal peptide binds to both c-SecA and u-SecA with similar affinities. 
This result was surprising at first because previous work showed that an activated form of 
SecA, SecA64, which lacks the C-terminal one-third of the protein, bound signal peptides 
better than full-length c-SecA (Triplett et al., 2001). Therefore, u-SecA in which the C-
terminal portion has undergone domain dissociation might also have been expected to 
bind signal peptides with a higher affinity. However, u-SecA is generated by low 
concentrations of urea, and besides pushing SecA into the activated form, the urea could 
also weaken signal peptide binding. Urea weakens non-covalent interactions and since 
signal sequence recognition is mediated through hydrophobic interactions, the binding 
affinity to u-SecA is likely decreased. In the case of c-SecA, part of the signal peptide 
adopts a helical conformation upon binding (Chou and Gierasch, 2005; Gelis et al., 2007) 
and in u-SecA the helical structure may be disrupted resulting in a decreased binding 
affinity.  
To test the specificity of c-SecA and u-SecA signal peptide interaction, a 
qualitative competition assay similar to the assay as described above was performed. The 
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concentration of both forms of SecA and the Bio-KRRLamB19C peptide was held 
constant at 1 µM and increasing amounts of the non-biotinylated signal peptide, 
KRRLamB WT (Figure 1.2, B), were added as a competitor. If the binding of the 
biotinylated signal peptide is specific, it should be displaced from SecA with the addition 
of the non-biotinylated signal peptide and result in a decrease in the biotin signal.  
For c-SecA, the non-biotinylated signal peptide starts to compete with the 
biotinylated peptide to a small degree with equimolar  amounts. When 20-fold excess 
KRRLamB WT is added, a little less than three-quarters of the biotinylated peptide is 
displaced (Figure 3.6, A, B). The concentration of signal peptide cannot be increased 
beyond 20-fold excess because it starts to induce higher oligomers/aggregation of c-
SecA. The competing peptide was equilibrated with the c-SecA for one minute because 
longer equilibration times showed little differences in the biotin signal. This suggests that 
the biotinylated form of the signal peptide may have a slightly higher affinity for c-SecA 
than the non-biotinylated form as well as has a relatively fast on/off rate. 
In the case of u-SecA, the equimolar amount of non-biotinylated signal peptide 
competes off about one-quarter of the biotinylated signal peptide. By 15-fold excess of 
the non-biotinylated signal peptide, more than three-quarters of the biotin signal has 
disappeared indicating that a majority of the biotinylated signal peptide has been 
displaced (Figure 3.6, C, D). If higher concentrations of signal peptides are used, u-SecA 
is pushed into the dimeric and aggregated forms. This dimerization/aggregation 
phenomenon with monomeric u-SecA is similar to SecA that was monomerized by 
phospholipid analogs. Monomeric SecA associated to the phospholipids is also 
dimerized/polymerized with the addition of high concentrations of signal peptide  
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Figure 3.6 Signal peptide competition assay 
 
Competition between biotinylated signal peptide and non-biotinylated signal peptide was 
monitored by gluteraldehyde cross-linking. A. Biotin detection (top) and Coomassie blue 
stained SDS-PAGE gel (bottom) of increasing concentrations of the competing 
KRRLamB WT signal peptide cross-linked to 1.0 µM each c-SecA and Bio-
KRRLamB19C signal peptide. The KRRLamB WT concentrations in the lanes are as 
follows: (1) 0 µM, (2) 1.0 µM, (3) 2.5 µM, (4) 5.0 µM, (5) 10.0 µM, (6) 12.5 µM, (7) 
15.0 µM, (8) 17.5 µM, (9) 20.0 µM. Dimeric SecA migrates at 204 kD while monomeric 
SecA migrates at 102 kD. B. Quantitation of the biotin signal in A based on three 
separate experiments. Dimeric SecA is shown by the red bars while monomeric SecA is 
shown by the blue bars. C. Biotin detection (top) and Coomassie blue stained SDS-PAGE 
gel (bottom) of increasing concentrations of the competing KRRLamB WT signal peptide 
cross-linked to 1.0 µM each u-SecA and Bio-KRRLamB19C signal peptide. The 
KRRLamB WT concentrations in the lanes are as follows: (1) 0 µM, (2) 1.0 µM, (3) 2.5 
µM, (4) 5.0 µM, (5) 10.0 µM, (6) 12.5 µM, (7) 15.0 µM. Dimeric SecA migrates at 204 
kD while monomeric SecA migrates at 102 kD. D. Quantitation of the biotin signal in C 
based on two separate experiments. Dimeric SecA is shown by the red bars while 
monomeric SecA is shown by the blue bars. 
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(Benach et al., 2003). For u-SecA the competing signal peptide needed to be equilibrated 
with u-SecA for one hour prior to cross-linking otherwise little competition was 
observed. This observation suggests that the signal peptide has a slow off-rate from u-
SecA.  
Due to the highly hydrophobic nature of the signal peptide, it is not surprising that 
all of the biotinylated signal peptide is not displaced in the competition assay. There is 
likely to be some level of non-specific interaction between SecA and the signal peptide 
that cannot be competed off of SecA in the gluteraldehyde cross-linking assay. Overall, 
these results demonstrate that c-SecA and u-SecA directly and specifically bind signal 
peptide. 
3.3.2. Analysis of SecA fragments cross-linked to signal peptide 
In order to determine the signal sequence-binding region on c-SecA and u-SecA, 
we employed a photoactivatable cross-linking approach. The Bio-KRRLamB19C signal 
peptide was labeled with 4-maleimido-benzophenone. Irradiation with UV light leads to a 
benzophenone diradical that has the ability to abstract a hydrogen atom from a nearby 
electron-rich σ-bond and upon recombination, forms a covalent linkage. If no suitable 
bond is present the diradical reacts with water making benzophenone (BP) a highly 
specific cross-linking reagent (Dorman and Prestwich, 1994). 
To discern if the signal sequence-binding site is different in c-SecA and u-SecA, 
we developed a strategy to compare the cross-linked proteolytic fragments of both forms 
of SecA (Figure 3.3, A (1-5)). This strategy enables us to determine differences in the 
cross-linking pattern between c-SecA and u-SecA. Any differences can be attributed to 
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alternative cross-linking and not differences in protease digestion between the two 
different conformations of SecA.  
In our initial studies, cross-linked proteins, c-SecA (Figure 3.7) and u-SecA 
(Figure 3.8), were subjected to limited chymotrypsin digestion over a time course ranging 
from 10 sec to 10 min. The digests were separated on tricine SDS-PAGE gels and 
analyzed by biotin and SecA region-specific antibody detection. The overall pattern of 
digestion, biotin, and antibody detection between c-SecA and u-SecA is similar but there 
are differences in the lower molecular weight bands in the biotin detection. The two 
minute time point of digestion (Figure 3.9) shows the biotin detection of SecA fragments 
around 66 kD corresponds to the A1, A2, A3, and A4 antibodies (see Chapter 2, Figure 
2.8), which represents the N-terminal two-thirds of the protein as previously 
demonstrated with SecA64. A smaller proteolytic fragment of about 45 kD is recognized 
by the A1 and A2 antibodies. These cross-linked  SecA fragments are present in both c-
SecA and u-SecA. Smaller molecular weight bands, approximately 30 and 20 kD are 
detected only in u-SecA. The antibodies that correspond to these bands are A5 and A6 for 
the 30 kD band and A3 and A4 for the 20 kD band (Figure 3.9, B red boxes). SecA has 
40 potential chymotrypsin digestion sites (calculated from ExPASy with a threshold set at 
75% (Gasteiger et al., 2005)) so several different proteolytic fragments of similar 
molecular weight can be generated. Therefore, mapping the identity of the cross-linking 
fragments by 1-D gel antibody detection is difficult.  
SecA is an acidic protein with a theoretical isoelectric point (pI) of 5.43 
(calculated from ExPASy) (Gasteiger et al., 2005). To further separate and identify the 
cross-linked SecA fragments, we chose to use two-dimensional gels. Isolectric focusing  
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Figure 3.7 Limited protease digestion of signal peptide cross-linked to c-SecA 
 
Cross-linking was were performed as c-SecA but then incubated in 2.2 M urea for four 
hours to have a similar chymotrypsin pattern as u-SecA. The lanes are as follows: (1) no 
digestion, (2) 10 sec, (3) 1 min, (4) 2 min, (5) 3 min, (6) 4 min, (7) 5 min, (8) 10 min. The 
labels of the different panels correspond to the different antibodies (A1 – A6), Coomassie 
blue stain (C) and Biotin detection (B). The molecular weight standard is indicated to the 
left of the Coomassie blue stained gel. A control of chymotrypsin alone was also included 
in the experiment but did not react with any of the detection methods so it is not shown. 
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Figure 3.8 Limited protease digestion of signal peptide cross-linked to u-SecA 
 
After incubated in 2.2 M urea for four hours to generate u-SecA, cross-linking was 
performed followed by protease digestion. The lanes are as follows: (1) no digestion, (2) 
10 sec, (3) 1 min, (4) 2 min, (5) 3 min, (6) 4 min, (7) 5 min, (8) 10 min. The labels of the 
different panels correspond to the different antibodies (A1 – A6), Coomassie blue stain 
(C) and Biotin detection (B). The molecular weight standard is indicated to the left of the 
Coomassie blue stained gel. A control of chymotrypsin alone was also included in the 
experiment but did not react with any of the detection methods so it is not shown. 
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Figure 3.9 Bio-KRRLamB19C-MBP cross-linking to both c-SecA and u-SecA 
 
A. The two minute time point from c-SecA limited protease digestion. The molecular 
weight marker is shown on the left and each lane is labeled with the corresponding 
detection, A1 – A6 antibodies, biotin detection (B), and Coomassie blue stain (C). B. The 
two minute time point from u-SecA limited protease digestion. The molecular weight 
marker is shown on the left and each lane is labeled with the corresponding detection as 
described above. The red boxes indicate biotin detected fragments that are only found in 
u-SecA. 
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(IEF) was performed using pH 4-7 IEF strips (Figure 3.3, (A6)). After IEF the SecA 
fragments were further separated by tricine SDS-PAGE (A7). The 2-D gels were 
transferred to polyvinylidene fluoride (PVDF) membrane (A8) for biotin (A9) and 
region-specific antibody (A10) detection.  
We analyzed the 2-D biotin detection of c-SecA and u-SecA blots (Figure 3.10) 
for cross-linked SecA fragments (Figure 3.3 (B1)) as described in the Materials and 
Methods. Only SecA fragments smaller than 50 kD were analyzed. Out of 21 potential 
fragments found on each blot, 12 fragments in c-SecA (Figure 3.11 A) and 18 fragments 
in u-SecA (Figure 3.11 C) were calculated to be above background signal (see Materials 
and Methods for description). The intensity of each spot was quantified (Figure 3.11 B, 
D) using ImageJ software (Abramoff et al., 2004) normalizing the data to the free signal 
peptide found at the bottom of both blots.  
C-SecA (Figure 3.11 A) and u-SecA (Figure 3.11 B) biotin detection blots were 
aligned using the Flicker software (Lemkin et al., 2005). Since focusing differences can 
arise during IEF, the Flicker software enables the alignment of two different gels as 
described in the Material and Methods. Flickering between the two gel images allows for 
visualization of overlapping cross-linked fragments in c-SecA and u-SecA. Several SecA 
fragments are the same in both biotin detections (S1-S13) but some of these fragments 
(S8-S11 and S13) were observed in c-SecA but were not above background signal to be 
defined as a fragment. In addition to having similar proteolytic fragments, three unique 
fragments in c-SecA, C1-C3, and five unique fragments in u-SecA, U1-U5 were found 
(Figure 3.11). 
  130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10 2-D gel biotin detection of signal peptide cross-linked to c- and u-SecA 
 
Bio-KRRLamB19C-MBP signal peptide was cross-linked to both c-SecA and u-SecA 
followed by digestion with chymotrypsin for two minutes. The digestions were separated 
by isoelectric focusing, 4-7 pH range, followed by molecular weight separation with 8% 
SDS-PAGE gels. A. Biotin detection of c-SecA proteolytic fragments. Yellow circles 
indicate potential spots (see materials and methods for spot determination). B. Same as in 
A but with u-SecA and orange circles indicating potential spots. 
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Figure 3.11 Analysis similar and different fragments in c- and u-SecA 
 
A. The biotin detection of 2-D gel for cross-linked c-SecA. Spots that are similar to u-
SecA are S1-S12 and spots that are different are C1-C3. Not all of the similar spots in c-
SecA are above background. B. Quantitation of the spots shown in A using the ImageJ 
software. Each spot was measured for biotin signal three times. C. The biotin detection of 
2-D gel for cross-linked u-SecA. Spots that are similar to c-SecA are S1-S13 and spots 
that are different are U1-U5. D. Quantitation of spots shown in C. Each spot was 
measured for biotin signal three times. 
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After biotin detection, each blot was probed with the different region-specific 
SecA antibodies. This enables the putative mapping of SecA fragments that are cross-
linked to signal peptide. Both the biotin and antibody probes were performed on the same 
blot, thus, allowing for the biotin probed gel to be aligned separately with each of the 
antibody detections using the Flicker software (Lemkin et al., 2005). The flickering 
between the two images enabled visualization of overlaying fragments between the biotin 
and antibody images. From this method, the SecA domain corresponding to the 
proteolytic fragment was determined. One striking feature that is apparent when 
comparing the biotin detection to the antibody detection is that the cross-linking is 
amazingly specific. Only a small subset of the all SecA proteolytic fragments were cross-
linked to the signal peptide. 
All the similar cross-linked fragments in c-SecA (Figure 3.12) and u-SecA 
(Figure 3.13) are recognized by exactly the same antibodies with the exception of the 
S12. This fragment was only recognized by the A4 antibody in c-SecA but was identified 
by the A3 and A4 antibodies in u-SecA. Using the mass spectrometry data from Chapter 
2 and the antibody detection data, we were able to determine the SecA chymotryptic 
fragments that were cross-linked to signal peptide (Figure 3.4, B). One subset of 
fragments represents cross-linking to the NBF I and PPXD domains of SecA. The S1-S5 
and S7-S8 fragments are recognized by the A1 and A2 antibodies. S1, S2, and S3 
fragments, about 40 kD in size, have slightly different isoelectric points (Figures 3.12 and 
3.13). These SecA proteolytic fragments represent residues 11-405 (Figure 3.4 B) but 
have different cleavage sites a few residues away at one or both of the termini. The S4  
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Figure 3.12 Antibody detection of 2-D gels of c-SecA cross-linked to signal peptide 
 
2-D gels were detected for biotin (B) and with the region-specific antibodies. The 
digested 1-D sample stained with Coomassie blue (C) with the molecular weights is 
shown to the left of the biotin image. The pH range for the IEF is shown on the top of the 
images. The lane on the left side of the image is cross-linked c-SecA sample that was not 
subjected to IEF. The yellow circles indicate the positions of the different SecA 
proteolytic fragments identified in the biotin image. 
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Figure 3.13 Antibody detection of 2-D gels of u-SecA cross-linked to signal peptide 
 
2-D gel were detected for biotin (B) and with the region-specific antibodies. The digested 
1-D sample stained with Coomassie blue (C) with the molecular weights is shown to the 
left of the biotin image. The pH range for the IEF is shown on the top of the images. The 
lane on the left side of the image is cross-linked u-SecA sample that was not subjected to 
IEF. The yellow circles indicate the positions of the different SecA proteolytic fragments 
identified in the biotin image. 
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and S5 fragments are approximately 24 kD in size and represent smaller proteolytic 
fragments of S1, S2, or S3. S4 and S5 include amino acids 80-299 and one of the 
fragments has a slightly different cleavage site resulting a different isoelectric point. S7, 
about 20 kD in size, and S8, approximately 17 kD, are two further proteolytic cleavages 
of the S1-S3 fragments (Figure 3.4, B). S7 is only detected by the A1 antibody while S8 
is exclusively detected by A2. 
Another subset of similar SecA proteolytic fragments cross-linked to signal 
peptide in both c-SecA and u-SecA maps to NBF II. The approximately 19 kD S12 
fragment is recognized by the A3 and A4 antibodies and includes residues 406-598. A 
second fragment, S13, is eight kD and has been further proteolyzed from the S12 
fragment. One other cross-linked fragment is the same in c-SecA and u-SecA belongs to 
the third subset, the HSD and HWD. S6 is about 20 kD and is recognized only by the A5 
antibody. This fragment includes residues 623-794 (Figure 3.4, B) 
Several biotin-detected fragments are specific for c-SecA and u-SecA. The three 
unique fragments found in c-SecA (Figure 3.12) belong to the NBF II subset. The larger 
C2 and C3 fragments, approximately 43 kD, are recognized by the A2, A3, and A4 
antibodies and correspond to residues 300-691. C2 and C3 are similar in molecular 
weight but differ slightly in isoelectric point indicating a small difference in digestion. A 
smaller unique c-SecA cross-linked fragment, C1 about 19 kD, represents a proteolytic 
fragment from C2 or C3. C1 is very similar to S12 but has a different isolectric point due 
to a different chymotrypsin cleavage site. 
In u-SecA five unique cross-linked fragments are observed (Figure 3.13) but only 
three of the five fragments were identified by antibody mapping. The two unidentified 
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fragments have low biotin signal (Figure 3.11, D) and probably do not contain enough 
SecA protein to be detected by the antibodies. The U1 fragment is in the NBF I and 
PPXD cross-linking subset. U1 is similar to S1, S2, S3 in molecular weight, isoelectric 
point, and antibody detection. Therefore, U1 is similar to the S1, S2, and S3 fragments 
but has a slightly different chymotrypsin digestion site. The U2 fragment is a member of 
the NBF II subset and is roughly 15 kD. This fragment is exclusively recognized by the 
A3 antibody and represents amino acids 406-541. U2 is very similar to S12 and S13 
fragments and is a further proteolytic fragment of S12. The third u-SecA specific cross-
linked fragment is part of the HSD and HWD subset. U4 is about 15 kD, recognized by 
A5 antibody, and corresponds to residues 623-762. This fragment is a smaller proteolytic 
piece from the S6 fragment. 
These results demonstrate that c-SecA and u-SecA share the same signal-
sequence binding site. Signal peptide cross-linking is observed to three regions of the 
protein indicating that the binding region is at the interface between NBFI, NBFII, 
PPXD, and N-terminal HSD. 
3.4. Discussion 
The mechanistic details of preprotein translocation through the SecYEG 
translocon by SecA are poorly understood. Activation of SecA by the addition of low 
concentrations of urea has provided us with a soluble translocation-active form with 
which to examine a critical step in the translocation process, signal sequence recognition. 
Several previous studies have probed signal sequence binding to the cytosolic form of 
SecA (Kimura et al., 1991; Triplett et al., 2001; Hunt et al., 2002; Baud et al., 2002; Chou 
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and Gierasch, 2005; Papanikou et al., 2005; Gelis et al., 2007) but only one study by 
Musial-Siwek et al. (Musial-Siwek et al., 2007) has tried to identify the signal sequence-
binding site on an activated form of SecA. This group performed cross-linking studies in 
lipid vesicles but based on its ATPase rate lipid-bound SecA is not in the same 
conformation as translocation-active SecA (Lill et al., 1990). 
These data argue that the signal sequence-binding site is located at the interface 
between NBF I, NBF II, PPXD, and HSD domains, which maps to an area similar to the 
‘clamp’ region proposed by Rapoport et al. (Zimmer et al., 2008) in their recent crystal 
structure of truncated SecA bound to SecYEG. This result is in conflict with previously 
determined signal sequence-binding sites (Musial-Siwek et al., 2007; Gelis et al., 2007). 
We used benzophenone-mediated (BPM) cross-linking combined with limited 
chymotrypsin digestion in conjunction with biotin and antibody detection to map the 
signal sequence-binding site. Due to the heterogeneous nature of the different proteolytic 
fragments of SecA, 2-D gels enabled us to examine SecA fragments of similar molecular 
weight since fragments are separated by IEF as well as molecular weight.  
The length of the maleimido-benzophenone cross-linker from the backbone of the 
residue to which it is attached to the end of the benzophenone (BP) moiety is 12 Å. BP 
can cross-link to electron-rich σ bonds in the side chains Leu, Val, Arg, and Lys (Dorman 
and Prestwich, 1994) but is most likely to cross-link to Met (Wittelsberger et al., 2006). 
To correlate our BPM cross-linking data to the NMR model of signal peptide bound to 
SecA, all of the favorable cross-linking residues within 20 Å of Met 19 in the NMR 
structure were examined. From this analysis, cross-linked SecA fragments should be 
recognized predominantly by the A1, A2, and A5 antibodies. In the 2-D gel analysis, 
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proteolytic fragments are strongly recognized by the A1, A2, A3, and A4 antibodies. Two 
fragments, S6 and U4, are recognized by the A5 antibody and both fragments have a low 
biotin signal meaning that this was not a predominant cross-linking site. One possibility 
for the lack of cross-linking to the HWD (A5 antibody recognition) is that the orientation 
of the signal peptide does not allow for cross-linking to this region but if the NMR model 
is correct then we should only have cross-linking to SecA fragments recognized by the 
A1 and A2 antibodies. An alternative explanation is that the fragments recognized by the 
A3 and A4 antibodies are rich in surface-exposed Met residues, a favored cross-linker for 
BP. All of the surface-accessible side chains of the Met from residues 351 to 664 in the 
NMR structure were examined and only two surface-exposed Met were found. Both of 
these Met are a great distance away from the region that was modeled to be the signal 
sequence-binding site. Therefore, our data clearly suggest that the signal peptide is 
binding in a different region than the one model by NMR or that there are actually two 
signal sequence-binding sites. 
The BPM cross-linking data from the 1-D gels showed differences in signal 
peptide cross-linking to c-SecA and u-SecA. U-SecA has smaller molecular weight biotin 
positive bands (Figure 3.9) despite both c-SecA and u-SecA being digested in the same 
condition. Although unique c-SecA and u-SecA cross-linked fragments were present in 
the biotin detection, further analysis shows that the unique fragments are similar to the 
other identified S-fragments (Figure 3.4). This result demonstrates that c-SecA and u-
SecA share the same signal sequence-binding site.  
Overall, u-SecA contains a greater number of unique biotin-positive fragments 
and this could result from a difference in chymotrypsin digestion or more favorable 
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cross-linking residues exposed to the signal peptide in the translocation-active form. A 
difference in chymotryptic digestion can be ruled out since the digestion pattern and 
relative band intensities in the Coomassie blue stained gels are identical for u-SecA and 
c-SecA (Figure 3.9). The greater number of cross-links to u-SecA is likely due to more 
favorable residues closer to the signal peptide. This suggests that the signal-sequence 
binding groove in u-SecA has expanded. This would explain why some SecA natural 
substrates such as LamB with the native signal sequence bind to cytosolic SecA with low 
affinity but bind with high affinity to the activated SecA (Triplett et al., 2001).  
Hunt et al. (Hunt et al., 2002) proposed the single-stranded nucleic acids (SS-NA) 
groove (Figure 3.1 A) as a potential site for preprotein binding. The ‘SS-NA groove’ 
occupies the interface of NBF I, NBF II, PPXD, and HSD. This is consistent with our 
data regarding the binding site for signal peptide in both c-SecA and u-SecA but in u-
SecA the domain dissociation causes the site to become extended. The ‘SS-NA groove’ 
in SecA is similar to other ssDNA grooves found in DNA helicases (Korolev et al., 1997; 
Velankar et al., 1999), which have structural homology with the NBFs of SecA. Signal 
sequence-binding to the SS-NA groove imply a molecular operate through a mechanism 
similar to the helicases, such that the motor domains power the translocation of 
preproteins in SecA as they unwinding of DNA in the helicases. 
Based on our data, we propose a model where signal sequences bind to the SS-
NA region originally proposed by Hunt et al. (Hunt et al., 2002). The binding region is 
the same in both the cytosolic and translocon-bound forms but in the latter form, the 
binding region has been expanded which could allow for better signal sequence-binding. 
This binding region is also in close proximity to the nucleotide-binding site. The signal 
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sequence binding affinity can therefore be modulated by the presence of different 
nucleotides in the binding pocket (Shin et al., 2006). Additionally, the signal sequence 
can suppress the rate of ATPase activity as seen in the case of SecA64 (Triplett et al., 
2001). This SS-NA binding region is in a region similar to the clamp region proposed by 
Zimmer et al. (Zimmer et al., 2008) based on the truncated SecA/SecYEG crystal 
structure. Therefore, we propose a mechanism where the signal sequence binds to the SS-
NA groove and the mature portion of the preprotein binds to the PPXD. After the 
proofreading step of signal sequence binding, ATP hydrolysis releases the signal 
sequence and pushes it into the translocon. 
During the course of this study, several experimental problems had to be resolved. 
A critical experiment was verifying that u-SecA interacts with signal peptide in a specific 
manner. This experiment was problematic do to the highly hydrophobic nature of the 
signal peptide and the propensity of u-SecA aggregate at protein concentrations above 2.5 
µM. Typical methods to assess binding such as size exclusion chromatography, 
isothermal titration calorimetry, and equilibrium dialysis were unsuccessful. To 
overcome this problem, we developed the qualitative gluteraldehyde cross-linking 
binding assay. Although this assay does not provide a binding constant, we showed that 
u-SecA indeed binds to signal peptide in a specific manner to further confirmed that u-
SecA is a translocation-active form of SecA. 
Another major obstacle we overcame was determining the region on c-SecA and 
u-SecA that was cross-linked to signal peptide. As shown in Chapter 2, c-SecA is less 
proteolytically labile than u-SecA and therefore, comparison of the cross-linked 
chymotryptic fragments was difficult. We developed a strategy (Figure 3.3, A (1-5)) that 
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enabled us to cross-link signal peptide to c-SecA and digest this cross-linked product in 
the same manner as u-SecA. One-dimensional SDS-PAGE revealed that the digestion 
pattern was identical but as demonstrated in MS experiments in Chapter 2, the 
heterogeneous nature of the chymotryptic SecA fragments generates different proteolytic 
fragments of the same size. This heterogeneous population made the antibody mapping 
difficult to interpret that prompted us to used two-dimensional gels to resolve this 
problem since the SecA proteolytic fragments of similar size have different isoelectric 
points (Figure 3.3, A (5-10)). This method helped us identify the SecA domains that were 
cross-linked to signal peptide. Unfortunately, MS experiments to identify the residues in 
SecA cross-linked to signal peptide were unsuccessful. Due to the high specificity of BP, 
the cross-linking efficiency is low, in our case less than 10%. We tried to purify the 
cross-linked SecA products using a monomeric streptavidin column but the presence of 
urea decreased biotin affinity for the column and therefore, cross-linked u-SecA could 
not purified. In the MS experiments several potential cross-linked SecA fragments were 
identified but we were unsuccessful in obtaining sequence information by MS/MS. The 
masses of the potential cross-linked fragments were mapped to the SecA sequence but 
these fragments either did not contain a favorable cross-linking residue or the size of the 
fragment was similar to two or more SecA proteolytic fragments. Thus, we relied on our 
domain mapping strategy using region-specific antibodies to identify sites of cross-
linking, which provided us a powerful method to determine the signal sequence-binding 
site on c-SecA and the translocation-active u-SecA. 
3.5. Materials and Methods 
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3.5.1. SecA titration Assay 
C-SecA at 2.5 µM protein concentration in 20 mM HEPES pH 7.5, 50 mM KCl, 1 
mM MgCl2, 1 mM DTT and u-SecA at 2.5 µM in 20 mM HEPES pH 7.5, 50 mM KCl, 1 
mM MgCl2, 1 mM DTT, 2.2 M urea were generated by incubated at 22°C for four hours. 
The biotinylated signal peptide, Bio-KRRLamB19C (Bio-
MMITLRKRRKLPLAVAVAAGVCSAQAMA), was held constant at one µM while the 
concentration of c-SecA and u-SecA from the previous equilibration step was titrated 
from 0.1 µM to 2 µM in a reaction volume of 40 µl. The samples were equilibrated for 
two hours at 22°C. After equilibration the samples were cross-linked by the addition of 
gluteraldehyde to a final concentration of 0.1% and incubated at room temperature for 
two minutes. Cross-linking reaction was quenched by the addition of 100 mM Tris pH 
8.0 and each sample was run in duplicate on two different 6% tricine SDS-PAGE gels. 
One gel was transferred to PVDF membrane while the other gel was stained with 
Coomassie Blue or with SYPRO Ruby (BioRad). 
3.5.2. Biotin detection  
Membranes were blocked overnight at 4°C in 5% non-fat milk in phosphate 
buffered saline with 0.1% tween-20 (PBS-T). The next day the membranes washed, and 
probed with a streptavidin-HRP conjugate (GE Healthcare) at a 1:1000 dilution in PBS-T 
for two hour at room temperature for gluteraldehyde cross-linking or overnight at 4°C for 
1-D and 2-D gels.  The cross-linked bands were detected using the SuperSignal West 
Pico kit (Pierce, Rockford IL) following the manufacture’s instructions. The signal was 
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visualized and recorded using a G:Box gel documentation unit (Syngene, Frederick, 
MD). 
3.5.3. Protein staining and visualization 
Gels were stained with either Coomassie Blue or SYPRO ruby protein stain 
(BioRad) overnight at room temperature with gentle shaking. The next day the gels were 
destained according to the manufacture’s protocol. For visualization the SYPRO ruby dye 
was excited with 254 nm light and recorded using a G:Box gel documentation unit 
(Syngene, Frederick, MD). Coomassie Blue stain was recording using white light in the 
G:Box gel documentation unit. 
3.5.4. Biotin signal quantification and normalization 
The signal from the biotin detection was quantified using ImageJ software 
(http://rsb.info.nih.gov/ij/docs/index.html) (Abramoff et al., 2004). The images were 
background subtracted and inverted so that the background was black and the fragments 
were gray/white. The rectangle tool was used to measure the area and the mean-gray 
value (pixels) in the cross-linked protein band (the size of the rectangle depended on the 
size of the band). For each measured band a corresponding rectangle of the same area 
was taken of the local background. The ImageJ software output is the area, the mean-gray 
value, and the absolute intensity (AI), which is calculated by the program as a product of 
the area times and mean-gray value. The relative intensity of each band was calculated by 
dividing the corrected absolute intensity by the absolute intensity of one µM Bio-
KRRLamB19C cross-linked to one µM SecA. The data was normalized for protein 
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concentration by quantification of the SYPRO Ruby stained or Coomassie Blue stained 
gel following a similar procedure outline above for biotin quantification. 
3.5.5. Signal peptide competition assay 
One µM of both c-SecA and u-SecA (in the buffers described above) were 
incubated at 22°C for four hours. Bio-KRRLamB19C signal peptide at one µM was 
added to both c-SecA and u-SecA and incubated at 22°C for 15 min. The samples were 
added to tubes containing KRRLamB WT signal peptide 
(MMITLRKRRKLPLAVAVAAGVMSAQAMA) from 0 – 20 µM. c-SecA was 
incubated with the non-biotinylated signal peptide for one min before addition of 0.1% 
gluteraldehyde. Cross-linking occurred at room temperature for two minutes before 
quenching with 100 mM Tris pH 8.0. In the case of u-SecA, the samples were incubated 
with the non-biotinylated signal peptide for one hour before cross-linking and quenching. 
Each sample was run in duplicate on two different 6% tricine SDS-PAGE gels. One gel 
was transferred to PVDF membrane while the other gel was stained with Coomassie 
Blue. Quantification of the biotin bands was performed as described above and the data 
were normalized for protein concentration from the Coomassie blue stained gels.  
3.5.6. Labeling of signal peptide with maleimido-benzophenone 
The Cys at position 19 of one mM Bio-KRRLamB19C signal peptide (GL 
Biochem (Shanghai) Ltd) in 20 mM HEPES pH 7.5, 1.2 mM TCEP buffer was alkylated 
by the addition of 1.5 mM 4-maleimido-benzophenone (MBP) (Sigma). The reaction was 
stirred for 30 minutes at room temperature and the reaction was quenched by the addition 
of TFA to lower the pH to ~2. The MBP-labeled peptide was purified by preparative RP-
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HPLC using a phenyl (25x250 mm, 10 mm, 300 Å, Vydac) column using an appropriate 
water/acetonitrile gradient. The purified MBP-labeled peptide was checked by analytical 
RP-HPLC with a phenyl (4.6x150 mm, 5 mm, 300 Å, Vydac) column using an 
appropriate water/acetonitrile gradient demonstrating that the purity of the MBP-labeled 
peptide was greater than 95%. The identity and purity of the peptide was confirmed by 
mass spectrometry analysis using an Esquire-LC Ion trap mass spectrometer (Bruker 
Daltonics, Billerica, MA). 
3.5.7. BPM cross-linking experiments 
In order to determine if there are differences in the signal peptide binding region 
between c-SecA and u-SecA, Bio-KRRLamB19C-MBP signal peptide was cross-linked 
to both forms. In the absence of light, 2.5 µM Bio-KRRLamB19-MBP was added to 2.5 
µM c-SecA in cross-linking buffer (20 mM HEPES pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 
mM DTT) and incubated for 15 min at room temperature to allow for complex formation. 
The sample was then illuminated with 365 nm light at ~5 cm distance for one minute to 
induce cross-linking. To obtain a chymotrypsin digestion pattern similar to u-SecA, urea 
was added to the cross-linked c-SecA sample to a final concentration of 2.2 M and 
incubated at 22°C for four hours. Prior to cross-linking, u-SecA was generated by 
incubation of 2.5 µM of SecA in 2.2 M urea cross-linking buffer for four hours at 22°C. 
Cross-linking of u-SecA was performed as described above followed by the addition of 
2.2 M urea buffer to obtain the same final volume as the c-SecA sample.  
3.5.8. Protease digestion and TCA precipitation 
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Samples were digested with chymotrypsin (1:150 w/w) at room temperature for 
either a time course of 10 sec to 10 min for 1-D gel analysis or for two minutes for 2-D 
gel analysis. Digestion was quenched by the addition of 5 mM of the protease inhibitor 
ABESF. For 2-D gels an aliquot of each sample was taken, run on an 8% tricine SDS-
PAGE gel, and stained with Coomassie Blue to ensure proper digestion. The samples 
were precipitated by the addition of one volume 100% trichloroacetic acid  (TCA) to four 
volumes of sample and then incubated overnight at -20°C. The precipitated proteins were 
pelleted by a spin at 15,800 x g in a microcentrifuge. The pellet was washed with cold 
acetone two times and dried at 95°C for 10 minutes. The dried protein pellets were 
resuspended in 3X SDS-PAGE buffer for 1-D gel analysis or in rehydration buffer for 2-
D gel analysis. 
3.5.9. 1-D gels  
After resuspension in the 3X SDS-PAGE buffer, the TCA precipitated samples 
were boiled in a water bath for five minutes. Each sample was run in duplicate on two 
different 6% tricine SDS-PAGE gels. One gel was transferred to PVDF membrane while 
the other gel was stained with Coomassie Blue. The membranes were probed 
streptavidin-HRP, as described above, and the different region-specific SecA antibodies 
as described in the previous chapter. 
3.5.10. 2-D gels 
TCA pellets for both c-SecA and u-SecA were resuspended in rehydration buffer 
(8 M urea, 2% CHAPS, 0.4% Biolytes). Isoelectric focusing (IEF) strips (7 cm) pH range 
4-7 were rehydrated with c-SecA and u-SecA samples according to manufacture’s 
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protocol (Method 1 Passive rehydration, BioRad) and incubated at room temperature for 
14-16 hours. The strips were focused using a linear voltage gradient according to the 
manufacture’s program (BioRad). After focusing the strips were frozen at -80°C until 
further use.  
Prior to running the second dimension, the strips were thawed at room 
temperature for 10 min. The strips were incubated in equilibration buffer I (6 M urea, 
0.375 M Tris pH 8.8, 2% SDS, 20% glycerol, 2% (w/v) DTT) for 10 minutes at room 
temperature followed by incubation in equilibration buffer II (6 M urea, 0.375 M Tris pH 
8.8, 2% SDS, 20% glycerol, 2.5% (w/v) iodacetamide) for 10 minutes. The polymerizing 
stacking gel was added to the top of an 8% Tricine SDS-PAGE gel and the strips were 
slide into the polymerizing gel to ensure complete contact between the IEF strips and the 
SDS-PAGE gel. A small well was created in order to run the non-IEF sample for 
comparison to the IEF sample. After separation by SDS-PAGE, the gels were transferred 
to PVDF membrane and probed with streptavidin-HRP, as described above, and the 
different region-specific SecA antibodies as described in the previous chapter. 
3.5.11. 2-D gel data analysis 
To compare the cross-linking pattern between c-SecA and u-SecA, the Biotin 
detection of both proteins was analyzed using Flicker program 
(http://open2dprot.sourceforge.net/Flicker/) (Lemkin et al., 2005). Due to various 
distortions and other variations between the two samples, the Flicker program morphs 
and aligns two different images. In brief, three SecA fragments that are similar in both 
images were selected as landmarks.  These landmarks were used to affine warp the 
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images resulting in the alignment of these landmarks. Flickering, which allows for rapid 
flickering between the two overlaid images was enabled and similar and different cross-
linked fragments in c-SecA and u-SecA were visualized.  
The SecA proteolytic fragments from the biotin detection were manually picked 
and analyzed using the ImageJ software (Abramoff et al., 2004). Fragments that have a 
molecular weight lower than 50 kD were analyzed as described earlier except the circle 
tool was used to define the fragment. Two criteria were used to define a fragment. The 
biotin signal intensity must have fit completely inside the area of a circle with a minimum 
radius of 5.0 pixels and a maximum radius of 10.5 pixels. This definition was used to 
eliminate small background speckles from the chemiluminescence as well as streaks of 
unfocused protein. The second criteria was that the mean-gray value of the fragment must 
be two times greater than the mean-gray value of the local background. Once a fragment 
has been defined, the AI of the local background was subtracted from the AI of the 
fragment. Finally, the relative intensity of each fragment was calculated by normalizing 
the data to the free signal peptide signal at the bottom of the gel. The average relative 
intensity of each fragment was determined by take three different measurements of the 
fragment using circles of different radii. If any of the mean-gray values of the fragments 
were not two times higher than the local background signal the fragment was eliminated 
from further analysis. 
The different region-specific antibodies were used to identify the cross-linked 
fragments. The Flicker program was used to align and identify the cross-linked fragments 
(biotin detection) with the corresponding antibody detection. Since the same membrane 
was used for all of the detections, the full-length SecA protein from the non-IEF sample 
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(left side of the gel) was used to align the different images. Once the images were 
aligned, flickering between the biotin image and antibody image was enabled which 
allowed for the identification of the cross-linked fragments. Any fragment that was not 
identified by the antibodies was eliminated. 
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CHAPTER 4 
SIGNIFICANT FINDINGS AND FUTURE DIRECTIONS 
4.1. Significant findings 
The translocation of preproteins across membranes is an essential step in the 
secretory pathway in all organisms. The bacterial secretory system requires three 
components to accomplish the translocation process: the signal sequence, SecA, and the 
membrane-embedded translocon. Although a significant amount of work has been 
performed on each of these components, the molecular details of the interaction between 
the signal sequence, SecA, the SecYEG translocon is still poorly defined. In this study, 
we were able to define a signal sequence-binding site on the cytosolic and the 
translocation-active conformations of SecA. Our work showed that both conformations 
share the same binding site but this site is likely expanded in the activated form.  
Our work demonstrated that the translocation-active form of SecA undergoes 
dramatic domain dissociation. Dissociation of the C-terminal domains HWD, HSD, and 
CLT creating the activated form of SecA is consistent with the highly active truncated 
SecA64, which is missing the C-terminal one-third of the protein. Previous studies have 
suggested that this C-terminal region of SecA is protease protected in translocation assys. 
The dissociation of the PPXD and HWD is needed for the binding of SecA to the 
SecYEG translocon as demonstrated by the recent crystal structure of truncated SecA 
bound to the SecYEG translocon (Zimmer et al., 2008). The C-terminal domains, HWD, 
C-terminal HSD, and CTL can form a 30 kD stable fragment upon protease digestion. 
This fragment is similar to the membrane inserted portion of SecA previously described 
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by Price et al. (Price et al., 1996). This observation suggests that the C-terminal domain 
association with the membrane may help stimulate SecA’s translocation activity. When 
SecA is pushed into the activated conformation, NBF I is also in a more proteolytic labile 
conformation. This observation is consistent with the binding of NBF I to SecYEG 
(Osborne and Rapoport, 2007) and that in our activated SecA NBF I is missing its 
interaction partner and therefore, exists is a more molten globular state. 
Although the exact interactions of full-length SecA with the translocon are still 
poorly understood, we propose a model where NBF I, NBF II, and PPXD interact directly 
with the SecY while the C-terminal one-third of SecA disengages from the rest of the 
molecule and either interact with other components of the translocation system or the 
phospholipids membrane. These interactions of the C-terminus cause it to adopt a 
protease protected state while also releasing the suppression of the ATPase activity of 
SecA. 
We have identified a signal-sequence binding site on SecA that is similar to the 
one proposed by Zimmer et al. (Zimmer et al., 2008) which is located at the interface 
between NBF II, PPXD, and N-terminal HSD. This result is in conflict with previously 
reported signal-sequence binding sites (see Chapter 3 Introduction for a full description 
of the other binding sites). All of these results suggest three different possibilities: (1) 
there are multiple signal-sequence binding sites on the cytosolic and actived forms of 
SecA, (2) one site is the actually signal-sequence binding site and the other sites are 
mature preprotein binding sites, and (3) all of the sites are mature preprotein binding 
sites. Although there is evidence that SecA interacts directly with the signal sequence, it 
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is also possible that the ‘reading’ of the signal sequence is performed by the translocon 
and not SecA. 
4.2. Future directions 
The development of a soluble translocation-active form of SecA has been useful 
in determining the conformational changes in the activated form of SecA as well as in 
mapping the signal sequence-binding site. Several questions regarding the mechanistic 
details of SecA translocation remain unanswered. How do the preprotein, SecA, and 
translocon work together? How does the preprotein remain in an unfolded conformation 
after release from SecB? Why does SecA interact with preproteins in the cytosolic and 
translocon-bound forms? These issue are explored and discussed in the sections below. 
4.2.1. Structure of translocation-active SecA bound to preprotein 
The crystal structure of truncated SecA/SecYEG (Zimmer et al., 2008) and the 
work presented in this study have provided details about the conformation of 
translocation-active SecA and interactions with signal sequences but this does not 
provide the entire picture for how these three molecules interact in-vivo. To further 
understand the nature of the interactions between preprotein, SecA, and SecYEG, more 
structural details are needed. Cryo-electron microscopy would be an excellent option to 
capture the SecA machine working to translocate the preprotein across the membrane. 
This kind of experiment would provide insight into the SecA mechanism and may also be 
applicable to other translocation machines. 
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4.2.2. Preprotein interactions after release from SecB 
At the onset of the SecA translocation cycle, the molecular chaperone SecB is 
released from the preprotein/SecA/SecYEG complex. An intriguing question is how is 
the non-translocated portion of the preprotein maintained in an unfolded state. There 
must exist a sort of competition between the folding and translocation of the preprotein. 
Single-molecule studies using fluorescence could monitor the folding of the non-
translocated portion of preprotein during the translocation process.  One possibility is that 
the pushing of the preprotein through the translocon provides enough force to keep the 
preprotein in the unfolded state. This question could also be addressed using by using 
single molecule techniques. 
4.2.3. SecA /protein interactions in the cytosol 
One rather puzzling question is why do preproteins interact with SecA in the 
cytosol since the productive nature of the interactions is for translocation. A recent study 
by Eser and Ehrmann (Eser and Ehrmann, 2003) suggests that SecA might actually 
function in a quality-control manner to assist cytosolic proteins to fold by excluding them 
from the secretory pathway. The partitioning of SecA between the membrane and the 
cytosol indicates SecA could indeed have duel roles yet SecA can also recognize 
preproteins in the cytosol. Further studies using single-molecule fluorescence may be 
able to aid in the understanding of how SecA is able to differentiate between a secretory 
and a cytosolic protein. These kinds of studies could also provide insight into how other 
chaperones discriminate between substrates. 
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